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A B S T R A C T
Background
Surgical site infection (SSI) rates vary from 1% to 5% in the month following surgery. Due to the large number of surgical procedures
conducted annually, the costs of these SSIs can be considerable in financial and social terms. Many interventions are used with the aim
of reducing the risk of SSI in people undergoing surgery. These interventions can be broadly delivered at three stages: preoperatively,
intraoperatively and postoperatively. The intraoperative interventions are largely focused on decontamination of skin using soap and
antiseptics; the use of barriers to preventmovement of micro-organisms into incisions; and optimising the patient’s own bodily functions
to promote best recovery. Both decontamination and barrier methods can be aimed at people undergoing surgery and operating staff.
Other interventions focused on SSI prevention may be aimed at the surgical environment and include methods of theatre cleansing
and approaches to managing theatre traffic.
Objectives
To present an overview of Cochrane Reviews of the effectiveness and safety of interventions, delivered during the intraoperative period,
aimed at preventing SSIs in all populations undergoing surgery in an operating theatre.
Methods
Published Cochrane systematic reviews reporting the effectiveness of interventions delivered during the intraoperative period in terms
of SSI prevention were eligible for inclusion in this overview. We also identified Cochrane protocols and title registrations for future
inclusion into the overview. We searched the Cochrane Library on 01 July 2017. Two review authors independently screened search
results and undertook data extraction and ’Risk of bias’ and certainty assessment. We used the ROBIS (risk of bias in systematic reviews)
tool to assess the quality of included reviews, and we used GRADE methods to assess the certainty of the evidence for each outcome.
We summarised the characteristics of included reviews in the text and in additional tables.
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Main results
We included 32 Cochrane Reviews in this overview: we judged 30 reviews as being at low risk of bias and two at unclear risk of bias.
Thirteen reviews had not been updated in the past three years. Two reviews had no relevant data to extract. We extracted data from 30
reviews with 349 included trials, totaling 73,053 participants. Interventions assessed included gloving, use of disposable face masks,
patient oxygenation protocols, use of skin antiseptics for hand washing and patient skin preparation, vaginal preparation, microbial
sealants, methods of surgical incision, antibiotic prophylaxis and methods of skin closure. Overall, the GRADE certainty of evidence
for outcomes was low or very low. Of the 77 comparisons providing evidence for the outcome of SSI, seven provided high- or moderate-
certainty evidence, 39 provided low-certainty evidence and 31 very low-certainty evidence. Of the nine comparisons that provided
evidence for the outcome of mortality, five provided low-certainty evidence and four very low-certainty evidence.
There is high- or moderate-certainty evidence for the following outcomes for these intraoperative interventions. (1) Prophylactic
intravenous antibiotics administered before caesarean incision reduce SSI risk compared with administration after cord clamping (10
trials, 5041 participants; risk ratio (RR) 0.59, 95% confidence interval (CI) 0.44 to 0.81; high-certainty evidence - assessed by review
authors). (2) Preoperative antibiotics reduce SSI risk compared with placebo after breast cancer surgery (6 trials, 1708 participants; RR
0.74, 95% CI 0.56 to 0.98; high-certainty evidence - assessed by overview authors). (3) Antibiotic prophylaxis probably reduce SSI risk
in caesarean sections compared with no antibiotics (82 relevant trials, 14,407 participants; RR 0.40, 95% CI 0.35 to 0.46; moderate-
certainty evidence; downgraded once for risk of bias - assessed by review authors). (4) Antibiotic prophylaxis probably reduces SSI
risk for hernia repair compared with placebo or no treatment (17 trials, 7843 participants; RR 0.67, 95% CI 0.54 to 0.84; moderate-
certainty evidence; downgraded once for risk of bias - assessed by overview authors); (5) There is currently no clear difference in the
risk of SSI between iodine-impregnated adhesive drapes compared with no adhesive drapes (2 trials, 1113 participants; RR 1.03, 95%
CI 0.66 to 1.60; moderate-certainty evidence; downgraded once for imprecision - assessed by review authors); (6) There is currently
no clear difference in SSI risk between short-term compared with long-term duration antibiotics in colorectal surgery (7 trials; 1484
participants; RR 1.05 95% CI 0.78 to 1.40; moderate-certainty evidence; downgraded once for imprecision - assessed by overview
authors). There was only one comparison showing negative effects associated with the intervention: adhesive drapes increase the risk
of SSI compared with no drapes (5 trials; 3082 participants; RR 1.23, 95% CI 1.02 to 1.48; high-certainty evidence - rated by review
authors).
Authors’ conclusions
This overview provides the most up-to-date evidence on use of intraoperative treatments for the prevention of SSIs from all currently
published Cochrane Reviews. There is evidence that some interventions are useful in reducing SSI risk for people undergoing surgery,
such as antibiotic prophylaxis for caesarean section and hernia repair, and also the timing of prophylactic intravenous antibiotics
administered before caesarean incision. Also, there is evidence that adhesive drapes increase SSI risk. Evidence for the many other
treatment choices is largely of low or very low certainty and no quality-of-life or cost-effectiveness data were reported. Future trials
should elucidate the relative effects of some treatments. These studies should focus on increasing participant numbers, using robust
methodology and being of sufficient duration to adequately assess SSI. Assessment of other outcomes such as mortality might also be
investigated as part of non-experimental prospective follow-up of people with SSI of different severity, so the risk of death for different
subgroups can be better understood.
P L A I N L A N G U A G E S U M M A R Y
Overview of Cochrane Reviews of interventions used during surgery for preventing surgical site infection
What is the aim of this overview of reviews?
To identify and summarise all evidence from Cochrane Reviews on interventions to prevent surgical site infections (SSIs) that are
delivered while surgery is taking place (during the intraoperative period).
Key messages
We cannot be certain about the effectiveness in preventing SSI of the majority of intraoperative interventions, as we judged the certainty
of the evidence to be generally low or very low. In some circumstances (listed below), antibiotics were effective for the prevention of
SSI. There is no high- or moderate-certainty evidence for the relative effects of intraoperative interventions on mortality, and no data
at all for quality of life or costs. For these reasons, we cannot be certain whether these antibiotics, which are effective at preventing SSI,
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have any negative effects on mortality or quality of life. Larger trials with appropriate methods are needed to measure the outcomes
that are important to both patients and health professionals.
What was studied in the overview?
If bacteria get into a surgical cut during surgery, this can result in a wound infection commonly called an SSI. SSIs are one of the most
common forms of healthcare-associated infections, with around 1 in 20 surgical patients developing an SSI in hospital. SSIs can also
develop after people have left hospital. SSIs can result in delayed wound healing, increased hospital stays, increased use of antibiotics,
unnecessary pain and, in extreme cases, death. Their prevention is therefore a key aim for health services. Many interventions are
used to reduce the risk of SSI in people having surgery. These interventions can be delivered at three stages: before, during and after
the operation. It is therefore important to identify interventions that can reduce the incidence of SSIs. This overview focuses only on
interventions delivered during surgery.
What are the main results of the overview?
In July 2017 we searched for Cochrane Reviews involving interventions for preventing SSIs during surgery. We found a total of 32
Cochrane Reviews that could be included in this overview. Two reviews had no relevant data to extract so we extracted data from 30
reviews with 349 included trials, totaling 73,053 participants. Interventions assessed included use of disposable face masks and surgical
gloves, the use of oxygen during surgery, antiseptics for hand washing, patient skin preparation and cleaning the vagina before caesarean
section, methods of surgical incision and skin closure and use of antibiotics to prevent infection.
Evidence of at least moderate certainty indicates that the following interventions reduce SSI risk: (1) antibiotics administered via
drip before caesarean incision reduce SSI risk compared with administration after cord clamping (high-certainty evidence); (2) giving
antibiotics before surgery reduces SSI risk compared with placebo after breast cancer surgery (high-certainty evidence); (3) antibiotics
used topreventwound infections probably reduce SSIs for caesarean section comparedwith no antibiotics (moderate-certainty evidence);
(4) antibiotics used to prevent wound infections probably reduce SSI risk for hernia repair compared with placebo or no treatment
(moderate-certainty evidence); (5) iodine-impregnated adhesive drapes probably make no difference to SSI risk compared with no
adhesive drapes (moderate-certainty evidence); (6) there is probably no difference in SSI risk when antibiotics are given in the short-
term compared to the long-term during colorectal surgery (moderate-certainty evidence). One comparison showed that adhesive drapes
increase the SSI risk compared with no drapes (high-certainty evidence). Overall, we judged the certainty of evidence for our primary
outcomes (SSIs and death) to be low or very low.
Clinicians can use the evidence summarised in this overview to choose the best intervention for people having surgery. However,
many of the comparisons were supported by low- or very low-certainty evidence and so require further evidence to support future
decision making. This overview can also be used by policymakers in developing local and regional protocols or guidelines and can reveal
knowledge gaps for future research.
How up to date is this overview?
We searched for reviews that had been published up to July 2017. Of the 32 reviews included in this overview, 13 reviews had not been
updated in the past three years.
B A C K G R O U N D
Description of the condition
Millions of surgical procedures are conducted around the world
each year. Most procedures result in surgical wounds that heal by
primary intention, where wound edges are re-approximated using
sutures, staples, clips or glue. Some surgical wounds are left open
to heal (where closure is not appropriate because of infection,
physical impossibility of approximating wound edges or because
of the need to allow drainage) and some wounds break down
following closure; these open wounds heal from the ’bottom-up’
(known as ’healing by secondary intention’).
Surgical wounds are at risk from microbial contamination and
thus possible infection. Contamination may originate from the
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patient, for example when microbes on the skin enter a wound, or
from the surrounding environment, for example from operating
staff, the theatre, or wider hospital and home environments. SSIs
are relatively common: a recent US study with assessment in 183
hospitals involving 11,282 patients found that 452 people (4%)
developed hospital-acquired infection; of these, 21.8% were SSIs
(Magill 2014). Similar SSI incidence estimates have been reported
in France (Astagneau 2009). In the UK around 2% to 5% of sur-
gical patients develop SSIs (NICE 2008; Public Health England
2014) although the percentage varies greatly depending on the cir-
cumstances, including the contamination level of the surgery. In
England, a 2006 survey of hospital-acquired infections reported
that 8%of patients in hospitals had an infectionwhile an inpatient,
of which 14% were considered SSIs (Hospital Infection Society
2007; Smyth 2008). Many quoted incidence estimates for SSI are
likely to be underestimates because infections that developed out-
side hospitals were not considered (Bruce 2001; Gibbons 2011).
While more data are available for Western healthcare settings, SSI
was identified as the leading cause of hospital-acquired infection
in a systematic review of studies in low- and middle-income coun-
tries (Allegranzi 2010).
SSI is a serious global issue that can lead to significant morbidity,
need for re-intervention and treatment (including antibiotic use),
delayed wound healing, and in very serious infections, the possi-
bility of death (Awad 2012; Brown 2014; CDC 2017). SSIs also
increase consumption of healthcare resources. Recent figures from
the UK suggest that SSIs lead to a median increased hospital stay
of 10 days (95% confidence interval (CI) 7 to 13 days) with an
associated median additional cost attributed to SSI of GBP 5239
(95% CI GBP 4622 to 6719) (Jenks 2014). The UK National
Institute for Health and Care Excellence (NICE) identified that
an SSI increased the costs of surgery by two to five times (NICE
2008). In the USA,De Lissovoy 2009 estimated that the extended
length of stay and increased treatment costs associated with SSIs
over a one-year period led to approximately 1 million additional
inpatient-days, costing an additional USD 1.6 billion.
SSI risk
A patient’s overall physical health can predict the risk of SSI, as
can the type of surgical procedure (in terms of potential for con-
tamination) and duration of surgery. These factors are collectively
included in the National Nosocomial Infections Surveillance risk
index (Gaynes 2001; SWI Task Force 1992), which proposes three
criteria to assess risk: American Society of Anesthesiologists (ASA)
score of 3, 4, or 5 (ASA 2014); wound class (see below); and du-
ration of surgery. Other risk factors for SSI are suggested; such as
if surgery is elective or emergency, but supporting data for these
risk factors are more limited.
Wound class
Wound class is assessed using the classification system adopted by
the Centres for Disease Control and Prevention (HICPAC 1999).
• Clean: non-infective operative wounds in which no
inflammation is encountered, and neither the respiratory,
alimentary, genito-urinary tract nor the oropharyngeal cavity is
entered. In addition these cases are elective, have primary
closure, and wounds are drained with closed drainage systems
when required.
• Clean/contaminated: operative wounds in which the
respiratory, alimentary, genital or urinary tract is entered under
controlled conditions and without unusual contamination.
Specifically, operations involving the biliary tract, appendix,
vagina and oropharynx are included in this category, provided no
evidence of infection or a major break in sterile technique is
encountered.
• Contaminated: fresh, accidental wounds, operations with
major breaks in sterile technique or gross spillage from the
gastro-intestinal tract, and incisions in which acute, non-
purulent inflammation is encountered.
• Dirty: old traumatic wounds with retained devitalised
(dead) tissue and those that involve existing clinical infection or
perforated viscera (internal organs or gut). This definition
suggests that organisms causing postoperative infection were
present in the operative field before the operation.
In the UK data from 232 NHS hospitals on 620,535 surgical
procedures reported SSI rates of: 0.5% for knee prosthesis; 1% for
cardiac surgery (non-coronary artery bypass graft); 0.6% for hip
prosthesis and 5% for limb amputation (all clean surgery) (Health
Protection Agency 2015). This is in contrast to the incidence of
SSI following surgery on the large bowel (contaminated surgery) of
9.7% (Health Protection Agency 2015). Europe-wide surveillance
also reports higher incidence of SSI in colon surgery (9.5% of
surgeries resulting in SSI) (ECDC 2013).
Definition of SSI
Although there is no single agreed diagnostic tool or protocol to
confirm the presence of an SSI, (Bruce 2001 identified 41 different
definitions for SSI and 13 grading scales), the Centers for Disease
Control and Prevention (CDC) definition is commonly used (
Horan 1992).
A superficial SSI is defined as: “an infection occurring within 30
days after the operation and only involving the skin and subcuta-
neous tissue of the incision that is associated with at least one of
the following:
• purulent drainage, with or without laboratory
confirmation, from the surgical site;
• organisms isolated from an aseptically-obtained culture of
fluid or tissue from the surgical site;
• at least one of the following signs or symptoms of infection:
pain or tenderness, localised swelling, redness or heat, and
superficial incision is deliberately opened by the surgeon and is
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culture-positive or not cultured. A culture-negative finding does
not meet this criterion;
• diagnosis of SSI by the surgeon or attending physician.”
A deep incisional SSI is defined as: “infection that occurs within
30 days after the operative procedure if no implant is left in place,
or within one year if an implant is left in place, and the infection
appears to be related to the operative procedure and involves deep
soft tissues (e.g. fibrous connective tissues and muscle layers) of
the incision associated with one of the following:
• purulent drainage from the deep incision, but not from the
organ/space component of the surgical site;
• a deep incision spontaneously dehisces (opens up) or is
deliberately opened by the surgeon and is culture-positive or not
cultured when the patient has at least one of the following
symptoms: fever or localised pain or tenderness;
• an abscess, or other evidence of infection involving the deep
incision is found on direct examination, during re-operation, or
by histopathologic or radiologic examination;
• diagnosis of a deep incisional SSI by a surgeon or attending
physician.”
Description of the interventions
Many interventions are used with the aim of reducing the risk
of SSI in people undergoing surgery. These interventions can be
delivered at three stages: preoperatively, intraoperatively and post-
operatively (Goodman 2017). For the purpose of this review we
define:
• the preoperative phase as the time period between the
decision for the need for surgery and when everything is ready
for the operation to start, that is, the patient is on the operating
table (for this review we have assumed that staff are ready to
proceed with surgery at this point - thus the preparation of
operative staff occurs in this preoperative period);
• the intraoperative phase is the time period from when the
patient is on the operating table to when the operation has
finished and the wound is closed (if relevant). We consider any
activity taking place after induction of anaesthesia to be in this
phase because this starts in the operating theatre itself. For this
review, where it is clear that antibiotics were given very soon
before the incision, we consider this to be intraoperative, that is,
prophylactic intravenous antibiotics administered less than 60
minutes before surgery;
• the postoperative phase as the time period from the end of
the intraoperative phase to resolution of surgical procedure
(which we acknowledge could take several, weeks or months for
some patients). We note that whilst dressings, wound drains and
negative pressure wound therapy are often placed over wounds at
the end of surgery, their use is predominantly outside of theatre,
so they are considered in the postoperative phase.
Table 1 details key intervention types used at each stage of the
operative pathway, but is not an exhaustive list.Most interventions
listed are probably independent of each other and would generally
be delivered concurrently. However, the interventions listed could
also be grouped together as a care bundle, where a care bundle is
defined as a group of three to five evidence-based interventions
that are delivered together.
This overview of reviews will focus on interventions delivered in
the intraoperative phase.
How the intervention might work
See Table 1. The interventions are largely focused on decontami-
nation of skin using soap and antiseptics; the use of barriers to pre-
vent movement of micro-organisms into wounds; and optimising
the patient’s own bodily functions to promote best recovery. Both
decontamination and barrier methods can be aimed at people un-
dergoing surgery and operating staff. Other interventions focused
on SSI prevention may be aimed at the surgical environment and
include methods of theatre cleansing and approaches to theatre
traffic (i.e. how the movement of staff in and out of theatre is
managed).
Why it is important to do this overview
The Cochrane Handbook for Systematic Reviews of Interventions de-
scribes a Cochrane overview of reviews as being “intended primar-
ily to summarize multiple Cochrane Intervention reviews address-
ing the effects of two or more potential interventions for a single
condition or health problem” (Becker 2011).
SSIs are a prevalent problem for global healthcare and their preven-
tion is amajor focus for healthcare providers internationally. There
are several Cochrane Reviews that draw together randomised con-
trolled trial evidence for individual interventions for the prophy-
laxis of SSIs along the preoperative, intraoperative and postopera-
tive pathway. Findings from these reviews have not been collated,
so a transparent and usable synthesis of this evidence is required.
This overview will aid decision makers aiming to draw together
Cochrane evidence that spans the SSI prevention pathway. It will
also be a useful resource for guideline developers, especially for the
key NICE guidelines, which have not been fully updated for sev-
eral years (NICE 2008). (A planned update of the guidelines was
announced in 2017.) This overview will also complement other
guidelines such as those produced by the World Health Organi-
zation (Allegranzi 2016a; Allegranzi 2016b).
O B J E C T I V E S
To present an overview of Cochrane Reviews of the effectiveness
and safety of interventions delivered during the intraoperative
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period aimed at preventing SSIs in all populations undergoing
surgery in an operating theatre.
M E T H O D S
Criteria for considering reviews for inclusion
Types of studies
We included reviews published in theCochrane Database of System-
atic Reviews that examine the effectiveness of interventions aimed
at preventing SSIs. We did not consider non-Cochrane reviews.
We only included systematic reviews of randomised controlled
trial (RCT) evidence for patient-focused interventions. If reviews
included other study designs alongside RCTs (e.g. controlled clin-
ical trials, quasi-randomised controlled trials, or both) we only in-
vestigated if RCT evidence was presented separately for relevant
analyses (e.g. as sensitivity analyses). If so, these RCT data were
included. If there were no separate data for RCTs in a review of
patient-focused interventions we did not include that review in
analyses. Primary RCTs published since the included reviews, but
not yet included in reviews, were excluded in line with Cochrane
guidance.
Where studies evaluated service-level interventions e.g. protective
staff coverings, theatre traffic and environmental cleansing, designs
such as interrupted time series and controlled before and after
studies were more feasible and we also extracted data from these
study designs as well as from RCTs (including cluster RCTs).
Types of participants
We included reviews of studies involving adults or children or both.
We excluded reviews where inclusion criteria specified that study
participants had infected wounds at baseline (i.e. treatment rather
than prevention reviews). Reviews that considered both treatment
and prevention studies were examined in detail to isolate relevant
comparisons.
We included reviews of participants undergoing surgery of any
contamination level (clean, clean/contaminated, contaminated
and dirty). Reviews focused solely on graft sites and wounds of
the mouth and eye were excluded. We included reviews looking
at surgical wounds planned to heal by primary intention (closed
wounds) and secondary intention (openwounds). Given their spe-
cialist nature, we excluded eye and oral surgeries and studies look-
ing at infection prevention in pin sites.
Types of interventions
We included reviews that assessed the following interventions
aimed at preventing SSIs during the intraoperative period of the
patient care pathway (regardless of comparator - all were eligible):
• decontamination of patients’ skin at site of surgery incision;
• use of intraoperative prophylactic antibiotics;
• skin sealants;
• use of standard and incise drapes;
• use of masks, hair covers, overshoes, gowns and other
protective coverings for theatre staff;
• different glove protocols;
• use of electrosurgery for surgical incisions;
• maintaining patient homoeostasis (warming);
• maintaining patient homoeostasis (oxygenation);
• maintaining patient homoeostasis (blood glucose control);
• wound irrigation and intracavity lavage (including use of
intraoperative topical antiseptics before wound closure);
• closure methods;
• theatre traffic (protocols for managing the movement of
people in theatre).
We excluded reviews focusing on comparisons of different surgi-
cal approaches for the same surgery (e.g. different techniques for
inguinal surgical repair; open versus closure of perianal wounds)
or other interventions specific to certain types of surgery or pro-
cedures. We also excluded studies comparing different anaesthe-
siology regimens and those investigating the use of implants or
internal devices.
Where interventions were delivered at multiple time periods in
the same studies, such as for assessment of antibiotics where treat-
ment was started in one phase and continued through multiple
phases (e.g. antibiotics started preoperatively and continued post-
operatively), data are presented in the overview that correspond
with the start of the treatment. Thus this intraoperative overview
includes reviews where the start of treatment was in the intraoper-
ative phase. Where a review contained trials that variously deliv-
ered interventions at different starting phases, we aimed to extract
and present data only for those trials relevant to the intraoperative
phase (that is where the treatment started in the intraoperative
phase).
Types of outcomes
We present data according to the time points used in reviews
(if reported). Where possible, we grouped data into follow-up of
30 days or less and follow-up of more than 30 days. If a review
presented data at many different time points, the overview authors
reported data from the time points closest to 30 days and one year,
noting where other time point data were available in the original
review.
Primary outcome
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SSIs
Occurrence of postoperative SSI as defined by the CDC criteria
(Horan 1992), or the study authors’ definition of SSI. Where
available we present data that differentiated between superficial
and deep-incisional infection.
Secondary outcomes
Mortality
All cause-postoperative mortality (e.g. we did not differentiate be-
tween infection-related mortality and other mortality from other
causes).
Health-related quality of life
We included quality-of-life assessments where they were reported
using a validated scale that presents a single global score (e.g. SF-
12, SF-36orEQ-5D) or a validated, disease-specific questionnaire.
Ideally, reported data were adjusted for baseline scores. We did not
include ad hoc measures of quality of life that were not likely to
be validated and would not be common to more than one trial.
We did not plan to report multiple domain scores from the same
measure but rather to report only overall scores for instruments
e.g. physical component summary score and mental component
summary score for the SF-36.
Cost-effectiveness
Findings that considered relative costs andbenefits simultaneously.
Search methods for identification of reviews
We searched the Cochrane Database of Systematic Reviews (CDSR)
using the search strategy presented in Appendix 2. Given the large
number of interventions relating to the review, the search terms
focused on identification of reviews linked to SSI rather than to
specific interventions. The search was undertaken on 01 July 2017
(CDSR 2017, Issue 7), after which we tracked any included re-
views for updates, and followed protocols in case of full review
publication until 25 July 2017 (CDSR 2017, Issue 7).
Data collection and analysis
Selection of reviews
Two overview authors independently screened review titles and
abstracts to identify potentially relevant inclusions. We obtained
the full text of all reviews thought to be potentially eligible for fur-
ther investigation. The same two overview authors independently
screened the full text of all potentially relevant resources for in-
clusion in the overview. We recorded reasons for exclusion of any
reviews excluded at this stage. Any disagreements were resolved
through discussion with a third overview author. Where overview
authors were also authors of included reviews we sought to avoid
bias by ensuring that decisions were made by two other overview
authors.
Data extraction and management
We extracted data into a predefined and piloted data extraction
form to ensure consistent data capture from each resource. Data
were extracted by one overview author and independently checked
by a second, with a third acting as arbiter where required. We
extracted the following data for each included resource:
• study identification, review authors’ details;
• review objectives;
• review inclusion and exclusion criteria;
• included settings;
• included populations, including types of surgery or
procedure and depth of incision;
• all relevant comparisons and associated time points;
• concurrent intervention types that were the same for all
intervention arms;
• numbers of relevant included RCTs;
• outcomes reported and details of reported outcome values;
• method and results of risk of bias and evidence quality
assessment;
• GRADE assessments;
• details of any subgroup and sensitivity analyses.
Where a comparison was included in more than one review, we
recorded the details multiple times (because it was relevant to
each review in which it was contained). However, we reported the
comparison only once for the review with the lowest risk of bias,
or the most recent review if there was no difference in risk of bias
assessment. We extracted meta-analysed data where possible and
single study datawhen pooled datawere not available: we extracted
effect sizes with 95% confidence intervals where possible. We also
extracted contextual information to enable narrative descriptions
of how data were pooled (or not) presented per comparison (e.g.
if some trials had been pooled for a comparison and some had
not). If any information from a review was unclear or missing,
we accessed the published reports of the individual trials. We did
not contact study authors for details of missing data, but rather
assumed that review authors had done all they could to retrieve
data. We entered data into Review Manager 5 software (RevMan
2014).
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Assessment of methodological quality of included
reviews
Quality of included Cochrane Reviews
We used the risk of bias in systematic reviews (ROBIS) tool
(Whiting 2016) to assess the risk of bias in systematic reviews.
ROBIS assesses reviews in three phases: first, assessing relevance
(optional); second, identifying concerns with the review process;
and third, forming an overall judgement of the risk of bias. In the
second phase, concerns with the review process fall into four do-
mains: (1) study eligibility criteria; (2) identification and selection
of studies; (3) data collection and study appraisal; and (4) synthesis
and findings. Each domain contains a list of signalling questions
to guide the bias assessment process. The signalling questions can
be answered yes, probably yes, probably no, no or no information.
Questions are worded so that a yes response relates to low concerns
about the review e.g. “Did the review adhere to pre-defined ob-
jectives and eligibility criteria? and were the eligibility criteria ap-
propriate for the review question?” At the end of each domain the
assessor draws together their appraisal to indicate their concerns
regarding: specification of study eligibility (domain 1); methods
used to identify and select studies, or both (domain 2); methods
used to collect data and appraise studies (domain 3); and the syn-
thesis and findings (domain 4). Concerns can be graded low, high
or unclear. We recorded the rationale or reasoning for decisions
at each stage, that is for the signalling questions and the level of
concern rated, in a table for each domain. As this overview only
included Cochrane Reviews and relevance was considered as part
of our screening and selection process, we did not assess relevance
using the ROBIS tool (an optional first phase). Two reviewers (ZL
and JD) assessed each review independently, without blinding, us-
ing a previously piloted standardised form based on the ROBIS
Guidance Document and consulted each other to resolve any dis-
cordance and to compile a consensus judgment for each domain.
We presented a summary of ROBIS results for each review using
table format, which lent itself to presentation of data for a large
number of reviews.
Quality or certainty of evidence extracted from included
reviews
It is important to present the quality or certainty of evidence from
each review. We present a GRADE assessment for each eligible
outcome and comparison. Where GRADE assessment was con-
ducted in the review we extracted this assessment; however, where
GRADE assessments were not available, the overview authors un-
dertook assessment (making it clear that they had conducted the
GRADE assessment post hoc).
When making decisions for the risk of bias domain, we down-
graded one level when studies had been classified at high risk of
bias for one or more domains and where they were classified at
unclear risk of bias for both domains that contributed to selection
bias, or both.
In assessing the precision of effect estimates for SSI we fol-
lowed GRADE guidance (GRADE 2013; Schünemann 2011a;
Schünemann 2011b).We planned to take a conservative approach
and calculated an optimal information size (OIS) for the SSI out-
come using conventional sample size calculation methods and as-
suming a relative risk reduction of between 20% and 30% (Guyatt
2011). The OIS is summarised below but should not be treated as
an optimal sample size for any future research. In GRADE assess-
ments, theOIS is used to assess the stability of confidence intervals
(CI) rather than to assess the appropriateness of a sample size to
detect a difference per se.
Reduction in SSI from 14% to 10% (80% power; alpha 5%) =
2070 participants overall. Although on average, SSI rates are lower
than 14% in many high-income countries, they can be higher in
some countries and figures vary by SSI risk of the patient. We
took 14% as a conservative upper estimate of SSI incidence and
calculated 40% relative risk reduction.
We used the GRADE default minimum overall sample size for
dichotomous outcomes of 300 in lieu of theOIS to assess precision
for mortality.
If the OIS was not met we downgraded one level.We downgraded
two levels if there were very few events (or very few participants
for continuous outcomes). If the OIS was met we downgraded
one level if the 95% CI failed to exclude important benefits and
harms, which we considered as a relative risk reduction or increase
of 25%.
Judgement of GRADE certainty was agreed through discussion
involving at least two overview authors and involving additional
overview authors where there were disagreements.
Data synthesis
The aim of this review is to present a detailed summary of treat-
ment-effect data for interventions aimed at SSI prevention. We
present all relevant comparisons grouped by intervention type (in-
cluding details of co-interventions when recorded). We also con-
sidered data according to the contamination level of surgery where
possible.Weuse tabular formats to present summaries of treatment
effects with a corresponding GRADE assessment for each com-
parison. Where possible we extracted meta-analysed data, along
with details of model type and measures of statistical heterogene-
ity. Where data had not been meta-analysed we report study-level
treatment effects. Results from review subgroup and sensitivity
analyses are also presented. We present all data in tabular, meta-
analysis or narrative formats.
Where applicable, we converted available data to risk ratios (RR).
Where this was not possible we present original data. We had
planned not to undertake re-analysis of data beyond conversions
to RR. However, due to the inclusion of multi-stage reviews (re-
views that evaluated interventions at different points on the care
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pathways, i.e. pre-, intra- or postoperative, or a combination of
these) we extracted data on only trials where the intervention was
started in the intraoperative phase. Where it seemed appropriate
for each comparison, the overview authors meta-analysed these
subsets of trials. We have cautiously pooled these data into a new
meta-analysis relevant to this overview of reviews, reporting the
results as RR with 95% CI (again, if the subsets of trials were re-
ported as odds ratios (OR), we converted available data toRR).We
did not plan to undertake a network meta-analysis within given
intervention types.
R E S U L T S
See Characteristics of included reviews Table 2; Characteristics of
excluded reviews Table 3.
Description of included reviews
The search generated 414 records 330 of which we excluded based
on the title and abstract, and 84 of which we assessed as full text.
Of these, 32 reviews were eligible for this review (See Table 2;
Figure 1). Of the included reviews:
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Figure 1. Study flow diagram
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• two focused on theatre staff attire (Tanner 2006; Vincent
2016);
• five focused on the preparation of the surgical site (Dumville
2015; Hadiati 2014; Haas 2014; Webster 2015; Wood 2016).
• two focused on the method of surgical incision
(Charoenkwan 2017; Cook 2014).
• five focused on patient homeostasis during surgery
(Buchleitner 2012; Campbell 2015; Grocott 2012; Kao 2009;
Wetterslev 2015). Of these, two were multi-stage reviews (that is
they included trials evaluating intraoperative interventions as
well as pre- or postoperative interventions, or both). In these
reviews we extracted the relevant trials focusing on intraoperative
intervention delivery for this review) (Buchleitner 2012; Grocott
2012).
• 12 reviews focused on the use of intraoperative prophylactic
antibiotics for preventing SSIs (Gurusamy 2011; Gurusamy
2013; Gyte 2014; Jones 2014; Lipp 2013; Low 2012; Mackeen
2014; Nabhan 2016; Nelson 2014;Sanabria 2010;
Sanchez-Manuel 2012; Smaill 2014). Most of these were multi-
stage reviews and again, we extracted only data from trials
delivering interventions that started in the intraoperative phase.
• six reviews focused on interventions for wound closure
(AL-Khamis 2010; Biancari 2010; Dumville 2014; Gurusamy
2014a; Gurusamy 2014b; Mackeen 2012).
SSIwas reported in 75%(24/32) of the included reviews;mortality
was reported in 19% (6/32) and health-related quality of life or
cost-effectiveness were not reported in any included review. Six per
cent (2/32) of the reviews, reported no outcome data relevant to
this overview (Campbell 2015; Low 2012). In total we extracted
data from 30 reviews with 349 included trials, totaling 73,053
participants. We present SSI outcome data for 77 comparisons
and mortality data for nine comparisons.
Of the 52 excluded full-text reviews, 48 focused on interventions
only relating to the pre- or postoperative phase (or both) and four
titles were at the protocol stage only (see Table 3; Figure 1).
Methodological quality of included reviews
ROBIS quality of included reviews
We rated the quality of included reviews using the ROBIS tool
signalling questions (Table 4; detailed assessments by signalling
questions are shown in Appendix 3) presenting the overall ’Risk
of bias’ assessment results for each review in Table 4.
Our judgements of the four domain assessment findings were as
follows:
• we judged study eligibility to be at low concern for all
included reviews;
• we judged the process of study identification and selection
to be at low concern for all included reviews;
• for data collection and study appraisal, we judged 91% of
included reviews to be at low concern. We deemed study quality
not fully assessed in four studies (Cook 2014; Low 2012; Tanner
2006; Vincent 2016) and we judged these as unclear;
• for synthesis and findings, we judged 97% (31/32) of
included reviews to be at low concern due to the synthesis being
unlikely to produce biased results. Only one review (Cook 2014)
did not consider clinical diversity across studies and bias was not
explicitly addressed in the synthesis; we judged this review at
high concern.
Overall risk of bias
We considered issues around risk of bias in all reviews. In terms
of the overall ’Risk of bias’ assessment, we judged 94% (30/32) of
reviews to be at low risk of bias.
Quality of evidence in included reviews
Of the 32 included reviews, 31% (10/32) reported a GRADE as-
sessment for the SSI outcome, whilst only one review (3%) re-
ported a GRADE assessment for the mortality outcome. No other
GRADE assessments were reported in the included reviews.
The overview authors undertook GRADE assessment of relative
treatment-effect data where no review-level GRADE assessment
was available. Overall, the GRADE certainty of evidence was low
or very low, as summarised in Table 5. Of the 77 comparisons
presenting SSI data, we judged 51% (39/77) as low certainty and
40% (31/77) as very low certainty. Of the nine comparisons pre-
senting mortality data, we judged 56% (5/9) as being at low cer-
tainty and 44% (4/9) as very low. Common reasons for downgrad-
ing the certainty of evidence were risk of bias of included studies,
imprecision and inconsistency.
Effect of interventions
Analysis of results
A detailed presentation of relative treatment-effect data and
GRADE assessments for all individual comparisons are in Table 5
and Table 6. Belowwe present a narrative summary of key findings
in an order of the process of the surgery.
Where included reviews contained trials investigating only intra-
operative phase interventions, we interpreted results using data
reported in the review, and did not return to the original studies.
Where data were reported as RR, with or without 95% CIs, we
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used the results directly from the reviews. Where data were re-
ported as OR, we converted data to RR if appropriate. When the
evidence was of very low certainty, we did not report RR in the
main text but we did clarify RR (or original OR) in Table 5 and
Table 6.
When reviews were multi-stage, that is they contained studies that
variously started interventions at the pre-, intra- or postoperative
stage (e.g. Antimicrobial prophylaxis for colorectal surgery (Nelson
2014)) we extracted data only for the trials relevant to this overview
and reported cautious re-analysis of these extracted trials (see Data
synthesis). Such re-analyses have been clearly marked in Table 5
and Table 6.
We present results by review, following an order relevant to the
clinical pathway. We have made it clear that where general details
of surgery were available we have reported these. Where there is
a lack of detail this reflects the lack of information in the initial
review. Further, we did not group the outcomes into follow-up of
30 days or less and follow-up of more than 30 days, as these time
points were not recorded by the original reviews when the review
authors did the meta-analysis.
1. Theatre staff attire
Two reviews investigated theatre staff attire interventions:
1.1. Double gloving for preventing SSIs
Tanner 2006 included two trials (125 participants) that compared
double latex gloving with double latex gloving with a liner in a
single comparison, however neither trial reported any SSI events
(low-certainty evidence; downgraded twice for imprecision - as-
sessed by overview authors).
No other outcome data relevant to the overview were reported.
1.2. Disposable face masks for preventing SSIs
Vincent 2016 included three trials (2106 participants) that com-
pared disposable face mask use with no mask in a single compari-
son. Due to clinical heterogeneity, the review did not pool data.
SSI
Available trial evidence reports no clear difference in SSI risk fol-
lowing use of disposable face masks compared with no mask (low-
certainty evidence; downgraded for once for imprecision and once
for inconsistency - assessed by overview authors).
No other outcome data relevant to the overview were reported.
2. Preparation of the surgical site
Six reviews reported interventions used to prepare the surgical site.
2.1. Skin antiseptics for preventing SSIs after clean surgery
Dumville 2015 included 13 trials (2623 participants in total) and
evaluated a large number of different interventions , resulting in
12 comparisons of different types of skin antiseptic solutions and
scrubs on SSI risk.
SSI
Available evidence largely reports no clear difference between dif-
ferent types of skin antiseptics on SSI risk. The certainty of ev-
idence for the majority of these comparisons was low or very
low. Data from one trial (542 participants) suggested that 0.5%
chlorhexidine in methylated spirit may reduce SSI risk compared
with povidone iodine paint (RR 0.47, 95% CI 0.27 to 0.82; low-
certainty evidence; downgraded once for risk of bias and once
for imprecision - assessed by overview authors). The review also
grouped interventions together in an analysis based on whether
treatments were aqueous or alcoholic. Data from six trials (1400
participants) showed no clear difference between aqueous solu-
tions and alcoholic solutions (RR 0.77, 95%CI 0.51 to 1.17; low-
certainty evidence; downgraded once for risk of bias and once for
imprecision - assessed by overview authors).
No other outcome data relevant to the overview were reported.
2.2. Skin preparation following caesarean section for
preventing SSIs
Hadiati 2014 included five trials (1466 participants in total) and
presented four different comparisons: one comparing drapes with
no drapes (two trials with 1294 participants) and three (172 par-
ticipants) comparing different skin antiseptics.
SSI
Available trial evidence reports no clear difference between com-
pared treatments on SSIs risk (low- and very low-certainty evi-
dence; variously downgraded once for risk of bias and once or
twice for imprecision - assessed by overview authors).
No other outcome data relevant to the overview were reported.
2.3. Vaginal preparation with antiseptic solutions for
preventing SSIs
Haas 2014 included six trials (2205 participants) that compared
antiseptic solutions with placebos in a single comparison.
SSI
Available trial evidence reports no clear difference between com-
pared treatments on SSI risk (low-certainty evidence; downgraded
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once for risk of bias and once for imprecision - assessed by review
authors).
No other outcome data relevant to the overview were reported.
2.4. Plastic adhesive drapes for preventing SSIs
Webster 2015 included seven trials (4195 participants in total)
and presented two comparisons.
SSI
The first comparison compared adhesive drapes with no drapes
(five trials, 3082 participants) and found that use of adhesive
drapes was associated with an increase in SSI risk (RR 1.23, 95%
CI 1.02 to 1.48; high-certainty evidence - assessed by review au-
thors). The second comparison compared iodine-impregnated ad-
hesive drapes with no adhesive drapes (two trials; 1113 partici-
pants). Available trial evidence reports no clear difference in SSI
risk (RR 1.03, 95%CI 0.66 to 1.60; moderate-certainty evidence;
downgraded once for imprecision - assessed by review authors).
No other outcome data relevant to the overview were reported.
2.5. Microbial sealants for preventing SSIs
Wood 2016 included seven trials (859 participants in total) that
compared application of cyanoacrylate microbial sealants with no
microbial sealant in a single comparison.
SSI
Available trial evidence shows no clear difference in SSI risk be-
tween treatments (RR 0.53, 95% CI 0.24 to 1.18; low-certainty
evidence; downgraded once for risk of bias and once for impreci-
sion - assessed by overview authors).
No other outcome data relevant to the overview were reported.
3. Making the surgical incision
3.1. Scalpel versus electrosurgery for major abdominal
incisions
Charoenkwan 2017 included 11 trials (2178 participants) com-
paring scalpel with electrosurgery in a single comparison.
SSI
Available trial evidence reports no clear difference between com-
pared treatments on SSI risk (RR 1.07, 95% CI 0.74 to 1.54; low-
certainty evidence; downgraded for risk of bias and imprecision -
assessed by review authors).
No other outcome data relevant to the overview were reported.
3.2. Scalpel versus no-scalpel incision for vasectomy
Cook 2014 included two trials (1182 participants in total) that
compared scalpel versus no-scalpel incision for vasectomy. As these
two trials differed in their duration of follow-up and the level of
operator experience with the no-scalpel technique, the review did
not pool data.
SSI
It is uncertain whether no-scalpel incision reduces SSI risk (very
low-certainty evidence; downgraded once for risk of bias, once for
imprecision and once for heterogeneity - assessed by overview au-
thors). Based onROBIS, we assessed this review as being at unclear
risk of bias because it used a limited ’Risk of bias’ assessment pro-
cess; and also due to the lack of information about data synthesis.
The review authors did not state why synthesis was done for only
some of their outcomes.
No other outcome data relevant to the overview were reported.
4. Treatment of the patient during surgery
4.1. Warming of intravenous and irrigation fluids
Campbell 2015 included 24 studies (1250 participants in total).
No outcome data relevant to the overview were reported.
4.2. Intensive glycaemic control for preventing SSIs
Buchleitner 2012 included 12 trials (1403 participants in total).
We categorised only two included trials (105 participants) as de-
livering interventions that started in the intraoperative phase.
SSI
We considered the reported outcome, ’infectious complications’ to
be synonymous with SSIs and pooled the data from these two tri-
als (105 participants). It is uncertain whether intensive glycaemic
control reduces SSI risk when compared with conventional gly-
caemic control (RR 0.71, 95%CI 0.22 to 2.26; very low-certainty
evidence; downgraded twice for imprecision and once for incon-
sistency - assessed by overview authors).
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Mortality
We pooled the data from two trials (105 participants). It is un-
certain whether intensive glycaemic control reduces mortality risk
compared with conventional glycaemic control (RR 1.23, 95%
CI 0.18 to 8.43; very low-certainty evidence; downgraded twice
for imprecision, once for inconsistency - assessed by overview au-
thors).
No other outcome data relevant to the overview were reported.
4.3. Perioperative glycaemic control regimens for preventing
SSIs
Kao 2009 included five trials (743 participants in total). We cate-
gorised only three included trials (589 participants) as delivering
interventions that started in the intraoperative phase.
SSI
Evidence from one trial (78 participants) showed no clear differ-
ence in SSI risk when applying intra- and postoperative strict gly-
caemic control (using intravenous insulin) compared with con-
ventional glycaemic control (RR 0.48, 95% CI 0.04 to 5.03; low-
certainty evidence; downgraded twice for imprecision - assessed
by overview authors). One trial (371 participants) showed no clear
difference when applying strict intraoperative glycaemic control
(using insulin infusion) with conventional glycaemic control (RR
0.86, 95% CI 0.30 to 2.52; low-certainty evidence; downgraded
twice for imprecision - assessed by overview authors). Another trial
(140 participants) reported outcomes for pneumonia and wound
infections and we did not consider these data. Due to variation in
SSI outcomes we did not pool these trials in this overview.
Mortality
Evidence from 1 trial (78 participants) showed no clear difference
in overall mortality risk when applying intra- and postoperative
strict compared with conventional glycaemic control (RR 0.81,
95% CI 0.30 to 2.20; low-certainty evidence; downgraded twice
for imprecision - assessed by overview authors). Similarly, another
trial (371 participants) showed no clear difference when applying
intraoperative strict compared with conventional glycaemic con-
trol (RR 9.05, 95% CI 0.49 to 166.88; low-certainty evidence;
downgraded twice for imprecision - assessed by overview authors).
The potential for harm represented in the imprecision reported is
important to acknowledge here.
No other outcome data relevant to the overview were reported.
4.4. Increased global blood flow for preventing SSIs
Grocott 2012 included 31 trials (5292 participants in total). We
categorised 15 included trials (1202 participants) as delivering
interventions that started in the intraoperative phase.
SSI
Five included trials (353 participants) reported SSI data, which we
pooled. Increased global blood flow (e.g. fluids and/or inotrope;
oesophageal doppler) may reduce SSI risk compared with no treat-
ment (RR 0.40, 95% CI 0.19 to 0.82; low-certainty evidence;
downgraded once for imprecision and once for inconsistency - as-
sessed by overview authors).
Mortality
Fifteen relevant trials (1202 participants) reported mortality and
we pooled these data. There was no clear difference in mortality
risk following interventions to increase global blood flow com-
pared with no treatment (RR 0.67, 95% CI 0.40 to 1.13; low-
certainty evidence; downgraded twice for imprecision - assessed
by overview authors).
No other outcome data relevant to the overview were reported.
4.5. High perioperative inspiratory oxygen fraction for
preventing SSIs
Wetterslev 2015 included 28 trials (9330 participants in total).
Of these, we categorised 15 included trials (7219 participants) as
delivering interventions that started in the intraoperative phase.
SSI
Fifteen relevant trials (7219 participants) reported SSI data, which
we pooled. There was no clear difference in SSI risk following
use of 60% to 90% oxygen compared with 30% to 40% oxygen
(RR 0.87, 95% CI 0.71 to 1.07; low-certainty evidence; down-
graded once for risk of bias and once for inconsistency - assessed
by overview authors).
Mortality
Eight relevant trials (4918 participants) in this review found no
clear difference in mortality risk following use of 60% to 90%
oxygen compared with 30% to 40% oxygen (RR 1.07, 95% CI
0.87 to 1.33; low-certainty evidence; downgraded once for impre-
cision and once for heterogeneity - assessed by overview authors).
No other outcome data relevant to the overview were reported.
5. Use of antibiotics
5.1. Antibiotic prophylaxis versus no prophylaxis for
preventing infection after caesarean section
Smaill 2014 included 95 trials (more than 15,000 women). We
categorised all the included trials as delivering interventions that
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started in the intraoperative phase. In these trials antibiotic treat-
ment was continued postoperatively.
SSI
Eighty-two relevant trials (14,407 participants in total) reported
SSI data presenting a single comparison of antibiotics with no an-
tibiotics. Available trial evidence reports that antibiotic prophy-
laxis probably reduces SSIs (RR 0.40, 95% CI 0.35 to 0.46; mod-
erate-certainty evidence; downgraded once for risk of bias - as-
sessed by review authors).
No other outcome data relevant to the overview were reported.
5.2. Different classes of antibiotics given to women routinely
for preventing SSI at caesarean section
Gyte 2014 included 31 RCTs (7697 participants in total).
SSI
There were 19 relevant included trials (3559 participants in total).
Of these 17 trials specified the timing of administration, which
we categorised as the intraoperative phase, while two trials did
not specify the timing of administration. These trials reported SSI
data presenting four comparisons of different antibiotic prophy-
laxis regimes, including single cephalosporin, cephalosporin drug
combination, single penicillin and penicillin drug combinations.
All comparisons found no clear difference in SSI risk between the
different regimes used (low- or very low-certainty evidence; vari-
ously downgraded once or twice for risk of bias and imprecision -
assessed by overview authors).
No other outcome data relevant to the overview were reported.
5.3. Antibiotic prophylaxis for the prevention of methicillin-resis-
tant Staphylococcus aureus (MRSA)-related complications in surgi-
cal patients
Gurusamy 2013 included 12 trials (4704 participants in total). Of
these, we categorised seven trials (3393 participants) as delivering
interventions that started in the intraoperative phase. All these
trials continued antibiotic treatment postoperatively.
SSI
Six trials (3294 participants in total) presented 11 comparisons
of different prophylactic antibiotic regimens with each other, in-
cluding pefloxacin, cefazolin, ertapenem, cefotetan, cefamendole,
gentamycin, vancomycin, daptomycin, and cefuroxime. For all 11
comparisons there was no clear difference in SSI risk from use of
one antibiotic prophylaxis regime compared with another (low-
or very low-certainty evidence; variously downgraded for risk of
bias and imprecision - assessed by overview authors). One trial
(99 participants) compared antibiotic prophylaxis (co-amoxiclav
or cefotaxime) with no antibiotic prophylaxis and showed that re-
ceiving antibiotic prophylaxis with co-amoxiclav (or cefotaxime if
allergic to penicillin) may reduce SSI risk (RR 0.26, 95% CI 0.11
to 0.65; low-certainty evidence; downgraded twice for imprecision
- assessed by overview authors).
Mortality
Two relevant trials reported mortality. One trial (99 participants)
found no clear difference in mortality risk when using co-amoxi-
clav or cefotaxime compared with no antibiotic prophylaxis (RR
0.54, 95% CI 0.17 to 1.72; low-certainty evidence; downgraded
twice for imprecision - assessed by overview authors). A second
trial (884 participants) found no clear difference when using van-
comycin compared with cefuroxime (RR 2.02, 95% CI 0.18 to
22.18; very low-certainty evidence; downgraded once for risk of
bias and twice for imprecision - assessed by overview authors).
No other outcome data relevant to the overview were reported.
5.4. Prophylactic antibiotics for preventing SSIs after breast
cancer surgery
Jones 2014 included 11 RCTs (2867 participants). Of these we
categorised nine trials as delivering interventions that started in
the intraoperative phase.
SSI
Nine trials (2739 participants in total) presented three compar-
isons of different prophylactic antibiotic regimens. For the com-
parison of antibiotics delivered immediately prior to surgery com-
pared with placebo, we pooled data from six trials (1708 partici-
pants): the use of antibiotic reduced SSI risk (RR 0.74, 95% CI
0.56 to 0.98; high-certainty evidence - assessed by overview au-
thors). We also pooled the data from two trials (987 participants)
and the use of antibiotics immediately prior to surgery may reduce
the risk of SSIs compared with no treatment (RR 0.48, 95% CI
0.28 to 0.82; low-certainty evidence; downgraded once for im-
precision and once for inconsistency - assessed by overview au-
thors). One trial (44 participants) compared perioperative antibi-
otics with no antibiotic and found that it is uncertain whether
perioperative antibiotics reduce SSI risk (very low-certainty evi-
dence; downgraded once for risk of bias and twice for imprecision
- assessed by overview authors).
No other outcome data relevant to the overview were reported.
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5.5. Systemic antimicrobial prophylaxis for preventing SSIs
after percutaneous endoscopic gastrostomy (PEG)
Lipp 2013 included 13 RCTs (1637 participants in total) and we
categorised all trials as delivering interventions that started in the
intraoperative phase.
SSI
All trials reported peristomal infection as an outcome. A pooled
analysis (by review authors) of 12 trials (1271 participants) found
that prophylactic antibiotics may reduce the incidence of peris-
tomal infection (RR 0.39, 95% CI 0.30 to 0.51; low-certainty
evidence, downgraded twice for risk of bias - assessed by overview
authors). Another trial (334 participants) compared intravenous
(IV) antibiotics with antibiotics via PEG but the review authors
could not included it in the meta-analysis. The evidence reported
that it was uncertain whether there was a difference in peristomal
infection risk following treatment with systemic antibiotic (PEG)
compared with systemic antibiotic (IV) (RR 0.70, 95% CI 0.30
to 1.65 very low-certainty evidence; downgraded once for risk of
bias and twice for imprecision - assessed by overview authors).
No other outcome data relevant to the overview were reported.
5.6. Timing of intravenous prophylactic antibiotics for
preventing SSIs undergoing caesarean delivery
Mackeen 2014 included 10 trials (5041 participants in total) and
we categorised all trials as delivering interventions that started in
the intraoperative phase.
SSI
This review compared prophylactic intravenous antibiotics ad-
ministered before caesarean incision with administration after
cord clamping in a single comparison. Available trial evidence
reports caesarean antibiotic prophylaxis administered intraopera-
tively prior to incision reduced maternal SSIs (RR 0.59, 95% CI
0.44 to 0.81; high-certainty evidence - assessed by review authors).
No other outcome data relevant to the overview were reported.
5.7. Routes of administration of antibiotic prophylaxis for
preventing infection after caesarean section
Nabhan 2016 included 10 trials (1354 participants in total). Of
these we categorised seven trials (859 participants in total) as de-
livering interventions that started in the intraoperative phase.
SSI
Seven relevant trials (859 participants) reported SSI data. It is
uncertain whether IV antibiotics reduce SSIs risk compared with
irrigation (very low-certainty evidence; downgraded once for risk
of bias and twice for imprecision - assessed by review authors).
No other outcome data relevant to the overview were reported.
5.8. Antibiotic prophylaxis for preventing SSIs in patients
undergoing elective laparoscopic cholecystectomy
Sanabria 2010 included 11 trials (1664 participants in total).
We categorised all included trials as delivering interventions that
started in the intraoperative phase.
SSI
Eleven trials (1664 participants) reported SSI data presenting a
single comparison of antibiotic prophylaxis with placebo or no
prophylaxis. It is uncertain whether antibiotic prophylaxis reduces
SSI risk in this comparison (very low-certainty evidence; down-
graded twice for risk of bias and once for imprecision - assessed by
overview authors).
No other outcome data relevant to the overview were reported.
5.9. Antibiotic prophylaxis for hernia repair
Sanchez-Manuel 2012 included 17 trials (7843 participants in
total).We categorised all included trials as delivering interventions
that started in the intraoperative phase.
SSI
Seventeen trials (7843 participants) reported SSI data presenting
a single comparison of antibiotic prophylaxis with placebo or no
treatment. Available trial evidence reports that antibiotic prophy-
laxis probably reduces SSI risk (RR 0.67, 95% CI 0.54 to 0.84;
moderate-certainty evidence; downgraded once for risk of bias -
assessed by overview authors). Based on ROBIS, however, we as-
sessed this review as being at unclear risk of bias due to a limited
risk of bias assessment processes being used. This means that the
overview authors were unable to fully assess the risk of bias for all
domains recognised in the current version of the Cochrane ’Risk
of bias’ tool. We have not downgraded further for this review-level
issue.
No other outcome data relevant to the overview were reported.
5.10. Antimicrobial prophylaxis for preventing SSIs in
colorectal surgery
Nelson 2014 included 260 trials (43,451 participants in total) and
68 different antibiotics. Of these, we categorised 22 included trials
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(3604 participants in total) as delivering interventions that started
in the intraoperative phase.
SSI
Twenty-two trials (3604participants) presented six comparisons of
different antibiotic regimens or different routes of administration
of antibiotic prophylaxis. For the comparison of antibiotic with
no antibiotic/placebo, we pooled the data from five trials (405
participants) and found that antibiotic may reduce SSI risk (RR
0.25, 95% CI 0.16 to 0.41; low-certainty evidence; downgraded
once for risk of bias and once for imprecision - assessed by overview
authors).
For the comparison of duration of therapy, we pooled data from
seven trials (1484 participants) and found probably no difference
in SSI risk with short-term compared with long-term duration
antibiotic (RR 1.05, 95% CI 0.78 to 1.40; moderate certainty
evidence; downgraded once for imprecision - assessed by overview
authors).
For the comparison of additional aerobic coverage, we pooled data
from four trials (230 participants) and found that, with added aer-
obic coverage, an antimicrobial prophylaxis regimen may slightly
reduce SSI risk compared with no additional aerobic coverage (RR
0.38, 95% CI 0.16 to 0.96; low-certainty evidence; downgraded
once for risk of bias and once for imprecision - assessed by overview
authors).
For the comparison of additional anaerobic coverage, we pooled
data from four trials (1098 participants) and found that, with
added anaerobic coverage, an antimicrobial prophylaxis regimen
may slightly reduce SSI risk compared with no additional anaer-
obic coverage (RR 0.65, 95% CI 0.47 to 0.90; low-certainty evi-
dence; downgraded once for risk of bias and once for imprecision
- assessed by overview authors).
For the comparisons of the different routes of administration of
antibiotics from one trial (72 participants), it is uncertain whether
oral antibiotics reduce SSI risk compared with intravenous routes
(RR 2.11, 95% CI 0.20 to 22.29; very low-certainty evidence,
downgraded once for risk of bias and twice for imprecision - as-
sessed by overview authors). Evidence from one trial (310 partic-
ipants) showed no clear difference when applying combined oral
and intravenous antibiotics compared with oral or intravenous an-
tibiotics alone (RR 0.50, 95% CI 0.23 to 1.11; low-certainty evi-
dence, downgraded once for risk of bias and once for imprecision
- assessed by overview authors).
No other outcome data relevant to the overview were reported.
5.11. Methods of decreasing infection to improve outcomes
after liver resections
Gurusamy 2011 included seven trials (521 participants in total).
Only two included trials reported mortality data, which we cate-
gorised as delivering interventions that started in the intraopera-
tive phase.
Mortality
One trial (180 participants) compared long-duration antibiotics
with short-duration antibiotics; however there were no events in
either arm in this trial (very low-certainty evidence; downgraded
once for risk of bias, once for imprecision and once for publication
bias - assessed by review authors). Another trial (59 participants)
compared topical povidone iodine gel with no topical povidone
iodine gel. It is uncertain whether topical povidone iodine gel
reduces mortality risk (very low-certainty evidence; downgraded
once for risk of bias, once for imprecision and once for publication
bias - assessed by review authors).
No other outcome data relevant to the overview were reported.
5.12. Perioperative antibiotics to prevent infection after first-
trimester abortion
Low 2012 included 19 trials (9715 participants in total). No out-
come data relevant to the overview were reported.
6. Management of theatre traffic
No reviews examined management of theatre traffic.
7. Wound irrigation
No reviews examined wound irrigation.
8. Wound closure
8.1. Continuous versus interrupted skin sutures for non-
obstetric surgery
Gurusamy 2014a included five trials (827 participants in total)
and of these, four trials (602 participants in total) reported SSI
data.
SSI
Evidence from four trials (602 participants) showed that it is un-
certain whether continuous skin sutures reduce SSI risk compared
with interrupted skin sutures (very low-certainty evidence; down-
graded once for risk of bias and twice for imprecision - assessed by
review authors).
No other outcome data relevant to the overview were reported.
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8.2. Subcutaneous closure versus no subcutaneous closure
after non-caesarean surgical procedures
Gurusamy 2014b included six trials (815 participants in total) that
compared subcutaneous closure with no subcutaneous closure in
a single comparison.
SSI
Evidence showed that it is uncertainwhether subcutaneous closure
reduces SSI risk (very low-certainty evidence; downgraded once for
risk of bias and twice for imprecision - assessed by review authors).
No other outcome data relevant to the overview were reported.
8.3. Techniques and materials for skin closure in caesarean
section for preventing SSIs
Mackeen 2012 included seven trials (1104 participants in total)
and presented two comparisons reporting SSI risk.
SSI
For the comparison of staples with absorbable subcuticular suture,
data from six trials (916 participants) were pooled and there was no
clear difference in SSI risk following use of absorbable subcuticular
suture (RR 0.85, 95% CI 0.43 to 1.71; low-certainty evidence;
downgraded once for risk of bias and once for inconsistency -
assessed by overview authors). For the comparison of barbed suture
with polydiaxanone suture, data from one trial (188 participants)
showed no clear difference in SSI risk when using the different
types of sutures (RR 0.96, 95% CI 0.18 to 5.10; low-certainty
evidence; downgraded twice for imprecision - assessed by overview
authors).
No other outcome data relevant to the overview were reported.
8.4. Healing by primary versus secondary intention after
surgical treatment for pilonidal sinus
AL-Khamis 2010 included 26 trials (2530 participants in total)
and of these, 17 trials (1940 participants) reported SSI data.
SSI
Data from 10 trials (1231 participants) showed that it is uncertain
whether open healing reduces SSI risk compared with midline clo-
sure (RR 1.31, 95% CI 0.93 to 1.85; very low-certainty evidence;
downgraded once for risk of bias, once for imprecision and once
for inconsistency - assessed by overview authors). Data from five
trials (541 participants) showed midline closure may increase the
rate of SSIs compared with other closure (RR 3.72, 95 5 CI 1.86
to 7.42; low-certainty evidence; downgraded for risk of bias and
imprecision - assessed by overview authors). Evidence from one
trial (68 participants) showed that it is uncertain whether classic
Limberg reduces SSI risk compared with modified Limberg (very
low-certainty evidence; downgraded once for risk of bias, twice for
imprecision - assessed by overview authors). Similarly, evidence
from another trial (100 participants) showed that it is uncertain
whether classic Limberg reduces SSI risk comparedwithKarydakis
(very low-certainty evidence; downgraded once for risk of bias and
twice for imprecision - assessed by overview authors).
No other outcome data relevant to the overview were reported.
8.5. Staples versus sutures for closing leg wounds after vein
graft harvesting for coronary artery bypass surgery
Biancari 2010 included three trials (322 participants in total) that
compared staple closure with suture closure in a single comparison.
SSI
It is uncertain whether staples reduce SSI risk compared with su-
tures (very low-certainty evidence; downgraded once for risk of
bias and twice for imprecision - assessed by overview authors).
No other outcome data relevant to the overview were reported.
8.6. Tissue adhesives for closure of surgical incisions
Dumville 2014 included 33 trials (2793 participants in total) and
of these, 22 trials (1731 participants in total) reported SSI data.
SSI
Twenty-two trials (1731 participants in total) presented six com-
parisons of tissue adhesives with different wound-closing tech-
nologies. There was no clear difference in SSI risk betweenwounds
closed with tissue adhesives and wounds closed using other meth-
ods reported (sutures, adhesive tape, staples or others) (low- or
very low-certainty evidence; variously downgraded for risk of bias
and imprecision - assessed by review authors).
No other outcome data relevant to the overview were reported.
9. Theatre cleansing
No reviews examined theatre cleansing.
D I S C U S S I O N
Summary of main results
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We have summarised the main results of the included reviews
by categorising their findings and GRADE assessment (GRADE
2013) (Table 7).
The relative effects of majority of included interventions are in-
conclusive due to the low or very low certainty evidence. Excep-
tions to this are listed below. All data listed relate to SSI. There was
no high or moderate certainty evidence for the relative effects of
intra-operative interventions on mortality and no outcome data
at all for quality of life or costs.
High quality evidence
• Prophylactic intravenous antibiotics administered before
caesarean incision reduce SSI risk compared with after neonatal
umbilical cord clamping (RR 0.59, 95% CI 0.44 to 0.81; high-
certainty evidence - rated by review authors).
• Adhesive drapes increase SSI risk compared with no drapes
(RR 1.23, 95% CI 1.02 to 1.48; high-certainty evidence - rated
by review authors) (negative effects).
• Preoperative antibiotics reduce SSI risk compared with
placebo after breast cancer surgery (RR 0.74, 95% CI 0.56 to
0.98; high-certainty evidence - assessed by overview authors).
Moderate quality evidence
• Antibiotic prophylaxis probably reduce SSI risk after
caesarean section compared with no prophylaxis (RR 0.40, 95%
CI 0.35 to 0.46; moderate-certainty evidence - rated by review
authors).
• Antibiotic prophylaxis probably reduce SSI risk compared
with placebo for hernia repair (RR 0.67, 95% CI 0.54 to 0.84;
moderate-certainty evidence - rated by overview authors).
• Iodine-impregnated adhesive drapes (compared with no
adhesive drapes); and duration of the use of antimicrobial
prophylaxis for colorectal surgery (short-term compared with
long-term duration antibiotic) probably lead to little difference
in SSI risk (moderate-certainty evidence - rated by overview
authors).
Overall completeness and applicability of
evidence
The evidence included in this overview covers all eligible Cochrane
Reviews. Of the 32 included reviews, seven could be consid-
ered up-to-date as they were published within the last two
years (Cochrane recommends updating reviews every two years)
(Campbell 2015; Dumville 2015; Nabhan 2016; Vincent 2016;
Webster 2015; Wetterslev 2015; Wood 2016).
In keeping with the nature of a Cochrane overview, this body of
work does not cover non-Cochrane reviews. Alternative or emerg-
ing strategies for prevention of SSIs may not yet have been cov-
ered in a Cochrane Review and thus these data are not included
here, for example, use of Triclosan-containing sutures in children
or laminar airflow ventilation systems. Once such strategies have
been assessed in new reviews, we can and will update this overview
accordingly.
Quality of the evidence
In assessing the quality of the evidence, we employed the ROBIS
tool to examine the reviews, and evaluated the authors’ conclusions
to ensure that they were appropriate based on the available data.
All 32 included reviews scored well across the ROBIS assessment,
likely due to the stringent reporting guidelines implemented by
Cochrane prior to publication.
We used GRADE to assess the quality of the evidence reported by
primary studies in the included reviews. The evidence presented
in the majority of comparisons (91%) was rated either low- or
very low-quality/certainty. The main reasons for downgrading the
certainty of evidence included bias in the primary trials and im-
precision, the latter caused by small sample sizes or low event rates,
or both. It must be noted that the overview authors might have
used different criteria to make GRADE assessments to the review
authors. For example in our process we used an OIS (optimal in-
formation size) and this informed our decisions on downgrading
for precision - this may not have been the case in other reviews. For
transparency, we have reported review authors’ GRADE decisions
but these may not calibrate well with our assessments.
Potential biases in the overview process
By only searching the Cochrane Library, and including only cur-
rent Cochrane Reviews we may have missed some key literature.
However, previous publications have referred to the higher-qual-
ity grading (high ROBIS score) in Cochrane Reviews due to the
basic criteria necessary for publication at any stage (protocol or
full review), suggesting that they may be the most reliable source
of evidence (Pollock 2017).
We have employed a standard GRADE process on the included
studies in reviews (Schünemann 2011a; Schünemann 2011b).
In one case we considered how a review-level issue of sub-op-
timal risk of bias assessment affected the GRADE assessment
(Sanchez-Manuel 2012). In this case we did not alter the level of
GRADE certainty given, but uncertainty on the quality of the re-
view providing the evidence that was graded must be recognised.
Agreements and disagreements with other
studies or reviews
Over the years, as new evidence from RCTs continues to emerge,
a steady stream of publications aim to provide a comprehensive
overview on the prevention of SSIs. This is a summary overview
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of current Cochrane Reviews, we are not aware of any similar
overviews of prevention for SSIs.
WorldHealthOrganization (WHO) guidelines on SSI prevention
have recently been published (WHO 2016). The WHO reviews
that underpin these guidelines (WHO 2016) were also split by op-
erative phase: preoperative, intraoperative and postoperative. The
methods used to conduct the systematic reviews that underpin
these guidelines were, in some cases, different to those of the corre-
sponding Cochrane Reviews included in this overview of reviews,
which means direct comparison between overview and guidelines
findings is not appropriate. The WHO reviews are standard sys-
tematic reviews, more recent ones, in some cases, include obser-
vational as well as randomised controlled trial data and have re-
view questions that, in some cases, differ in scope to correspond-
ing Cochrane Reviews (as do related alibility criteria). Focusing
on the respective findings of the guidelines and the overview for
the intraoperative phase, the guidelines include topics not covered
by Cochrane Reviews, such as maintenance of body temperature,
maintenance of adequate circulating volume control, discontinua-
tionof immunosuppressive agents anduse of laminar airflow venti-
lation systems. Additionally, intraoperative antibiotic prophylaxis,
considered as part of this overview, were only considered as pre- or
postoperative interventions in the guidelines. Four further inter-
ventions were considered in both the guidelines and this overview:
patient oxygenation, use of microbial sealants, blood glucose con-
trol and use of drapes. The WHO guidelines (WHO 2016) make
a strong recommendation with moderate-quality evidence for use
of 80% inspired oxygen intraoperatively and into the postopera-
tive period for adult patients under general anaesthesia with endo-
tracheal intubation. Our overview found low-certainty evidence
from one review (Wetterslev 2015) with 15 RCTs reporting no
clear difference in SSI risk following use of high perioperative
inspiratory oxygen fraction for adult surgical patients. Although
similar data were used in the analysis performed, unlikeWetterslev
2015, WHO 2016 conducted a subgroup analysis based on the
type of anaesthesia, and it is this subgroup analysis that informs the
recommendation made (on oxygenation). Use of surgical drapes
was also considered by both guidelines and our overview. This
overview considers two more RCTs than WHO guidelines, but
both sources report similar findings in that adhesive drapes appear
to increase the SSI risk compared with no drapes. Again, there
were no key differences in findings reported for microbial sealant
and blood glucose control.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
This overview provides the most up-to-date evidence on preven-
tion of SSIs from currently published Cochrane Reviews (intraop-
erative phase). Generally, we found insufficient or low-certainty
evidence for the effect of most interventions for preventing SSIs.
This comprehensive overview of Cochrane Reviews highlights the
current uncertainty regarding the effectiveness of the intraopera-
tive phase interventions as preventions for SSIs. It is important to
note that one review with high-certainty evidence showed harms
associated with the use of adhesive drapes; and another review also
with high-certainty evidence showed benefit when using prophy-
lactic intravenous antibiotics administered before caesarean inci-
sion. As there remains uncertainty on the use of a number of pro-
phylactic SSI prevention options, health professionals are likely to
follow local and national guidelines until more information be-
comes available.
Implications for research
The individual reviews and this overview have highlighted the lack
of good evidence for intraoperative interventions for SSI preven-
tion. Included reviews in this category focused on interventions
administered during the procedure (e.g. prophylactic antibiotics,
patient warming) and methods to reduce bacterial contamination
(e.g. glove changes, incise drapes). Just a few interventions altered
the surgical approach itself (e.g. closure methods, the use of elec-
trosurgical incisions). It is possible that different surgical tech-
niques may influence SSI and this may be an area in need of more
research. Most of the trials and the participants included in them
did not contribute to any reliable assessment of efficacy or harm,
which may lead to research waste. Robust randomised controlled
trials with good internal validity from use of appropriate meth-
ods of randomisation, blinding and analysis are required. Stud-
ies also need to have carefully considered sample size calculations
and recruitment strategies to ensure that they are not underpow-
ered. It is also important that the outcomes that are important
to patients and health professionals are measured. Future stud-
ies should use appropriate outcome measures that are consistent,
reliable, have internal and external validity, and are sensitive to
change in what is being measured. Consistent use of outcomes
and related definitions would maximise the value of data from
across multiple studies. Improving measurement of SSI, especially
after hospital discharge, is warranted to improve data collection in
this phase using validated patient-reported outcome (PRO) mea-
sures or methods for wound photography, or both, to complement
these. A core outcome set focused on surgical wounds may be
considered by developing and applying agreed, standardised sets
of outcomes in this area. Trials should also collect quality-of-life
data and consider incorporating cost-effectiveness analysis. Whilst
adverse events should be collected as part of a trial, additional data
on mortality and other rare events might be better collected as
part of observational, prospective studies - perhaps using routinely
collected data if possible. Crucially it is important to understand
the risk of death as a function of SSI severity and these data are
unlikely to be obtained from trials. This research also highlights
the need for review authors to update existing reviews to ensure
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that new studies are incorporated into existing reviews so that
Cochrane Reviews remain contemporary and relevant.
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A D D I T I O N A L T A B L E S
Table 1. Interventions aimed at preventing surgical site infections
Intraoperative intervention types Details Theories on how the intervention type
might work
For the patient
Decontamination of patients’ skin at site of
surgery incision
Before surgery, patients’ skin is disinfected
using antiseptic solutions such as povidone-
iodine or chlorhexidine at varying concen-
trations
The aim of preoperative skin antisepsis is
to reduce the risk of SSIs by reducing the
number of micro-organisms on the skin (
ACORN 2012; Mangram 1999).
Skin sealants Microbial sealants are liquids that are ap-
plied to the patient’s skin before surgery
and left to dry forming a protective film
over the planned incision site. Cyanoacry-
late, which is also used as a tissue adhesive,
can be used as a skin sealant
As with other barrier methods, the use
of skin sealants is focused on preventing
contamination of the surgical wound with
micro-organisms from the patient’s skin.
It is proposed that skin sealant use be-
fore surgery prevents any remaining micro-
organisms from migrating into the surgi-
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Table 1. Interventions aimed at preventing surgical site infections (Continued)
cal wound following skin decontamination
(Singer 2008).
Incise drapes Before a surgical incision is made, ster-
ile plastic adhesive (incise) drapes can be
placed onto cleansed skin. The surgical in-
cision is then made through the drape.
Drapes can be plain or impregnated with
antimicrobial products
Drapes are used as a barrier between the
incision and the patient’s skin, which, al-
though cleansed may harbour micro-or-
ganisms, such as at deeper levels of the
skin that cleansing cannot reach (Swenson
2008).
Use of electrosurgery for surgical incisions In electrosurgery, an electric current is used
to generate heat, which vaporises cellular
material, cutting the skin in place of a
scalpel. This can be used to cut skin from
the top surface down or used on deep skin
layers once an incision has been made with
a scalpel (Soderstrom 2003).
It has been suggested that using heat to
make a surgical incisionmay reduce the risk
of SSI
Maintaining patient homoeostasis (warm-
ing)
During surgery the patient’s bodily func-
tions need to be optimised to promote re-
covery; it is further postulated this may also
reduce the risk of SSI. Under general anaes-
thetic it is harder for the body to regulate its
own temperature and this can increase the
risk of perioperative hypothermia. Warm-
ing can be achieved using thermal insula-
tion such as blankets, or active methods
of warming that use machines to transfer
heat to the patient, and use of heated intra-
venous fluids (NICE 2016;Whitney 2015)
.
Undertaking warming aims to maintain
body temperature and prevent the de-
velopment of perioperative hypothermia,
which can lead to negative postoperative
outcomes, which potentially include SSI.
These interventions can also be used post-
operatively to mitigate the impact of pe-
rioperative hypothermia when it has not
been prevented
Maintaining patient homoeostasis (oxy-
genation)
During surgery under general anaesthetic
patients are intubated and supplied with
oxygen to maintain adequate oxygen per-
fusion to all tissues
It is suggested that the risk of SSI is higher
when tissue oxygenation is not optimised
during surgery. Some surgical protocols use
higher saturation levels of oxygen during
intubation to increase tissue oxygenation
levelswith the aimof reducingwound com-
plications such as SSI. High oxygen levels
have been linked to serious adverse events
such as blindness and death (Al-Niaimi
2009).
Maintaining patient homoeostasis (blood
glucose control)
Use of strict glycaemic control using med-
ications to maintain glucose levels during
surgery
Hyperglycaemia after surgery is postulated
to lead to increased risk of surgical com-
plications including infection (Ljungqvist
2005; Stephan 2002).
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Table 1. Interventions aimed at preventing surgical site infections (Continued)
Wound irrigation and intracavity lavage
(including use of intraoperative topical an-
tiseptics before wound closure)
Surgical irrigation and intracavity lavage
use fluids to wash out the surgical cavity
at the end of the surgical procedure before
the wound is closed. Both wound irriga-
tion and intracavity lavage can be altered
by: volume of irrigation fluid; mechanism
or timing of delivery; or solution composi-
tion (Barnes 2014).
The theoretical advantage of surgical
wound irrigation is to reduce the bacte-
rial load in a surgical wound, and thus the
risk of SSI, through a combination of wa-
ter pressure, dilution, or the application of
antimicrobial agents
Closure methods Surgical wounds canbe closed using sutures
(absorbable or not) staples, adhesive strips
or tissue adhesives. Some closure methods
can make use of sutures that are coated in
antimicrobial products
The timing of closure can also vary; some
wounds canbe left open for a period follow-
ing surgery and then closed (delayed clo-
sure)
There is a view that the method of surgi-
cal wound closure may impact on SSI risk.
There is limited background evidence on
mechanisms for SSI prevention, although
it has been suggested that the better the
seal the closure method obtains, the bet-
ter the barrier to microbial contamination
(Gurusamy 2014a).
For staff
Use of masks, hair covers, overshoes, gowns
and other protective coverings for theatre
staff
Protective coverings worn in theatre by staff
to limit the movement of micro-organisms
in theatre (Cooper 2003).
For example: masks over the face; dis-
posable shoe covers worn over standard
footwear and changed as required; dispos-
able or reusable gowns worn over standard
scrub outfits and changed as required
There are various coverings used in surgery
that are designed to act as a barrier between
the environment and the patient’s wound
to maintain a sterile operative field, such as
masks that aim to capture water droplets
being expelled. Masks contain one or two
very finely woven filters that can inhibit
bacteria. Masks cover the nose and mouth,
but there is concern that masks may be
worn incorrectly and allow air leaks from
the sides of the mask
Shoe coverings aim to limit the transfer of
external material in and out of theatres
Gowns cover standard surgical attire and
can be removed when contaminated and
replaced
Different glove protocols Surgical staff wear disposable gloves dur-
ing surgery. Gloves are used in a number of
ways intended to minimise microbial con-
tamination from staff to patients, including
double gloving (using two pairs of gloves),
the use of glove liners or cloth outer gloves
(Kovavisarach 2002; Laine 2004).
Gloves are a barrier intervention that aim to
prevent transfer of micro-organisms from
the staff member’s skin to the patient’s skin
or wound. Gloves also act as a barrier to
prevent staff from infection by patients
For the environment
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Table 1. Interventions aimed at preventing surgical site infections (Continued)
Theatre cleansing The theatre environment needs to be
cleaned regularly with detergents to disin-
fect surfaces. Daily deep cleaning is likely
to occur using various protocols for clean-
ing surfaces between patient surgeries, es-
pecially areas that are contaminated with
bodily fluid, or that are frequently touched
by staff. Recent technologies used for the-
atre cleansing include UVC light decon-
tamination and hydrogen peroxide vapour
treatment
Surgical instruments are also sterilised to
decontaminate them after use. Various pro-
tocols are used including steam sterilisation
and chemical sterilisation, which is used
when steam sterilisation is not feasible
Theatre cleaning can also involve the use of
ventilation systems, such as laminar airflow
systems, which supply filtered air into the
environment to limit numbers of airborne
micro-organisms
To avoid cross-infection, special protocols
may be developed for cleansing when sur-
gical patients are known to have specific in-
fections
All aspects of theatre cleansing aim to min-
imise numbers of micro-organisms present
in the theatre environment with the aim of
reducing the risk of SSI. (Spagnolo 2013).
Theatre traffic A surgical theatre can be a busy working
environment with people moving in and
out. This movement can be managed, for
example limiting the entrance and exit of
staff during surgery, and minimising visi-
tors into the theatre (e.g. partners ofwomen
undergoing caesarean sections) (Spagnolo
2013).
A key aim in the prevention of SSI is to
limit numbers of micro-organisms in the
operative environment. People moving in
and out of the operative field may increase
the risk of contamination. Visitors to the
theatre who have not undergone full hand
scrubbing protocols and so forth could also
potentially increase SSI risk
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Table 2. Characteristics of included reviews
Review
no.
First
review
author
+ year
Review
title
Total
number
of in-
cluded
RCTs
(and
partici-
pants)
Re-
view ob-
jective
Popula-
tion, in-
cluding
types of
surgery/
proce-
dure
and
depth of
incision
Main
inter-
vention
e.
g. nasal
decon-
tamina-
tion
Com-
parator
(s)
Relevant review
outcomes
Review
limita-
tions
Note
Primary Sec-
ondary
CD006213
AL-
Khamis
2010
Healing
by
primary
ver-
sus sec-
ondary
inten-
tion af-
ter surgi-
cal treat-
ment for
pi-
lonidal
sinus
26 stud-
ies
(n =
2530)
To de-
termine
the
relative
effects
of open
com-
pared
with
closed
surgical
treat-
ment
for pi-
lonidal
sinus on
the out-
comes of
time to
healing,
infec-
tion and
recur-
rence
rate
Any par-
ticipants
(over 14
years of
age) un-
dergoing
surgery
to treat
pi-
lonidal
sinus
disease;
surgical
treat-
ment
for pi-
lonidal
sinus;
varia-
tions of
depth of
incision
(no
details)
Any sur-
gi-
cal inter-
vention
where
the
wound
was left
open to
heal
or closed
by
sutures
Another
surgi-
cal inter-
vention
Time to
healing
SSI
Recur-
rence
Time to
return to
work
Other
compli-
cations
and
morbid-
ity
Partici-
pant
(patient)
satisfac-
tion
Cost
Length
of hospi-
tal stay
Pain
Quality
of life
Rate of
change
of
wound
volume
Wound
healing
rate
Opera-
tive time
Vari-
ations in
the sur-
gi-
cal tech-
niques
included
in each
group
when
con-
ducting
meta-
analysis
They
also
com-
pared
different
closed
surgical
treat-
ments
(midline
vs off-
midline
wound
closure
Within
each
group
there
were
varia-
tions
in the
surgi-
cal tech-
niques
used: for
exam-
ple, the
amount
of tissue
excised,
depth of
incision,
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Table 2. Characteristics of included reviews (Continued)
type
of suture
mate-
rial and
suturing
tech-
nique
used
CD008057
Biancari
2010
Staples
versus
sutures
for clos-
ing leg
wounds
after
vein
graft
harvest-
ing for
coro-
nary
artery
bypass
surgery
4 studies
(n = 839
leg
wounds
in 581
partici-
pants)
To com-
pare the
rates of
SSI and
wound
dehis-
cence of
staples
and
sutures
for skin
closure
after
saphe-
nous
vein
graft
harvest-
ing for
coro-
nary
artery
bypass
graft
surgery
People
under-
going
saphe-
nous
vein
graft
harvest-
ing for
CABG;
mini-
mally
invasive
vein
harvest-
ing was
excluded
Suture Staples Rates of
SSI
Sever-
ity of SSI
Time to
wound
healing
Rate of
wound
dehis-
cence
Length
of hospi-
tal stay
Pain
Cost
Patient
comfort
Lower
limb
revascu-
lariza-
tion
Only
3 studies
included
(322
legs)
were
pooled
into
meta-
analysis
1 study
was ex-
cluded
from the
pooled
analysis
because
each
wound
experi-
enced
both
methods
of
closure
and
there
was
the risk
of a unit
of analy-
sis error.
How-
ever
there
was no
statisti-
cally sig-
nifi-
cant dif-
ference
between
the
groups
in this
study.
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Table 2. Characteristics of included reviews (Continued)
CD007315
Buch-
leitner
2012a
Periop-
er-
ative gly-
caemic
control
for dia-
betic pa-
tients
under-
going
surgery
12 stud-
ies
(n =
1403)
To assess
the
effects of
periop-
er-
ative gly-
caemic
control
for peo-
ple with
diabetes
under-
going
surgery
Partici-
pants of
any age,
sex or
ethnicity
with
previ-
ously di-
agnosed
type 1
or 2
diabetes
mellitus
and
submit-
ted to
periop-
erative
gly-
caemic
control
Periop-
er-
ative gly-
caemic
control
proto-
col pro-
posed by
study
authors
that in-
volves a
more in-
ten-
sive con-
trol than
the con-
ven-
tional
care
Periop-
er-
ative gly-
caemic
con-
trol pro-
tocol de-
fined as
stan-
dard or
conven-
tional
care by
the
study
authors
Any
kind
of infec-
tious
compli-
cation
All-
cause
mortal-
ity
Hypo-
gly-
caemic
episodes
Cardio-
vascular
events
Renal
failure
Length
of ICU
and hos-
pital stay
Health-
related
quality
of life
Eco-
nomical
costs
Weight
gain
Mean
blood
glucose
during
inter-
vention
CD009891
Camp-
bell
2015
Warm-
ing of in-
tra-
venous
and irri-
gation
fluids for
prevent-
ing inad-
ver-
tent pe-
rioper-
ative hy-
pother-
mia
24 stud-
ies
(n =
1250)
To
estimate
the ef-
fective-
ness of
preoper-
ative or
intraop-
erative
warm-
ing, or
both, of
intra-
venous
and ir-
rigation
fluids
in pre-
venting
periop-
erative
hy-
pother-
Adults
under-
going
elective
or emer-
gency
surgery
(in-
cluding
surgery
for
trauma)
under
general
or re-
gional
(central
neu-
raxial
block)
anaes-
thesia,
Warmed
intra-
venous
fluids in-
cluding
all meth-
ods of
warm-
ing flu-
ids be-
fore ad-
minis-
tration
to the
patient
Warmed
irriga-
tion
fluids in-
cluding
any ir-
rigation
Other
warmed
fluid
inter-
ventions
Stan-
dard
care
Thermal
insula-
tion or
passive
warm-
ing
Active
warm-
ing
Preoper-
ative or
intraop-
erative
warm-
Risk
of hy-
pother-
mia
at any
point
during
surgery
and
temper-
ature
at the
end of
surgery
or on
admis-
sion to
postanaes-
thesia
care;
Major
Infec-
tion and
compli-
ca-
tions of
the sur-
gical
wound
Pressure
ulcers
Bleeding
compli-
cations
Other
cardio-
vascu-
lar com-
plication
Patient-
reported
out-
No data
of inter-
est to
overview
authors
reported
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Table 2. Characteristics of included reviews (Continued)
mia
and its
compli-
cations
during
surgery
in adults
or both fluids
adminis-
tered to
a body
cavity
that is
warmed
by any
method
ing, or
both, of
inspired
and in-
sufflated
gases
Preoper-
ative and
intraop-
erative
pharma-
cological
inter-
ventions
cardio-
vascular
compli-
cations
comes
All-
cause
mortal-
ity
Length
of
stay Un-
planned
high de-
pen-
dency
or inten-
sive care
admis-
sion
Adverse
effects
CD005987
Charoenkwan
2017
Scalpel
versus
electro-
surgery
for ma-
jor ab-
dominal
incisions
16 stud-
ies
(n =
2769)
To assess
the
effects of
electro-
surgery
com-
pared
with
scalpel
for ma-
jor ab-
dominal
incisions
People
under-
going
major
open ab-
dominal
surgery,
regard-
less of
the ori-
entation
of the
incision
(vertical,
oblique,
or trans-
verse)
and
surgical
setting
(elective
or emer-
gency)
Wound
cre-
ation us-
ing elec-
tro-
surgery
Wound
creation
using a
scalpel
Wound
infec-
tion
Time to
wound
healing
Wound
dehis-
cence
Wound
incision
time
Wound-
related
blood
loss
Postop-
erative
pain
Adhe-
sion or
scar for-
mation
Sub-
group
anal-
ysis was
planned
but not
possible
to carry
out due
to inter-
ventions
being in-
suffi-
ciently
homo-
geneous
and
badly re-
ported.
Sensitiv-
ity anal-
ysis was
planned
by
exclud-
ing stud-
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ies at
high or
un-
clear risk
of bias.
How-
ever, this
was not
possible
as none
of the in-
cluded
studies
were at
low risk
of bias
CD004112
Cook
2014
Scalpel
ver-
sus no-
scalpel
incision
for va-
sectomy
2 studies
(n =
1529)
To com-
pare the
effec-
tive-
ness, sa-
fety, and
accept-
ability of
the inci-
sional
ver-
sus no-
scalpel
ap-
proach
to the
vasec-
tomy
Men
of repro-
ductive
age un-
dergoing
vasec-
tomy for
sterilisa-
tion
No-
scalpel
Scalpel Post-va-
sectomy
adverse
events
(includ-
ing
wound
infec-
tion)
Operat-
ing time
Pain
Time to
resump-
tion
of inter-
course
Rates for
azoosper-
mia
Time to
azoosper-
mia
Preg-
nancy
Inci-
dence of
recanal-
ization
Inci-
dence of
re-
peat va-
sectomy
Cost
analysis
Con-
sumer
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accept-
abil-
ity mea-
sures
Provider
accept-
abil-
ity mea-
sures
CD004287
Dumville
2014
Tissue
adhe-
sives for
closure
of surgi-
cal inci-
sions
33 stud-
ies
(n =
2793)
To de-
termine
the
effects of
various
tissue
adhe-
sives
com-
pared
with
conven-
tional
skin
closure
tech-
niques
for the
closure
of sur-
gical
wounds
People
of any
age and
in
any set-
ting re-
quir-
ing clo-
sure of a
surgical
skin in-
cision of
any
length
Tissue
adhesive
An-
other tis-
sue ad-
hesive or
alterna-
tive con-
ven-
tional
closure
device
Wound
dehis-
cence
Propor-
tion of
infected
wounds
Cos-
metic
appear-
ance
Pa-
tient sat-
isfaction
Sur-
geon sat-
isfaction
Cost
Time
taken to
wound
closure
CD003949
Dumville
2015
Preoper-
ative
skin an-
tiseptics
for pre-
venting
surgical
wound
infec-
tions af-
ter clean
surgery
13 stud-
ies
(n =
2623)
To de-
termine
whether
preop-
erative
skin an-
tisepsis
imme-
diately
prior to
surgical
incision
for clean
surgery
prevents
SSI and
People
of any
age un-
dergo-
ing clean
surgery
Antisep-
tic solu-
tions or
powders
A con-
trol; an-
other
type
of anti-
septic
or differ-
ent dose
SSI Quality
of life
Adverse
events
Re-
source
use
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to deter-
mine the
com-
parative
effec-
tiveness
of alter-
native
antisep-
tics
CD004082
Grocott
2012a
Periop-
erative
increase
in global
blood
flow to
explicit
defined
goals
and out-
comes
fol-
lowing
surgery
31 stud-
ies
(n =
5292)
To
describe
the
effects
of in-
creasing
periop-
erative
blood
flow
using
fluids
with or
without
in-
otropes
or va-
soactive
drugs.
Out-
comes
were
mortal-
ity, mor-
bidity,
resource
utiliza-
tion and
health
status
Adults
(aged ≥
16 years
) under-
going
surgery
in an op-
erating
theatre
Periop-
erative
adminis-
tration
(ini-
tiated
within
24 h
before
surgery
and
lasting
up to 6
h after
surgery)
of fluids,
with or
without
in-
otropes
or va-
soactive
drugs to
increase
global
blood
flow
against
explicit
mea-
sured
goals
Control Mor-
tality (at
longest
avail-
able fol-
low-up)
Mor-
tality: all
reported
time
frames
Morbid-
ity
Re-
source
utilisa-
tion
Health
status
Sub-
group
analysis
and sen-
sitiv-
ity anal-
ysis were
done
CD008726
Gyte
2014a
Dif-
ferent
classes
of an-
tibiotics
31 stud-
ies
(n
= 7697
women)
To de-
termine,
from
the best
available
Women
under-
go-
ing cae-
sarean
Prophy-
lactic an-
tibi-
otic regi-
mens
Differ-
ent
classes of
antibi-
otics (≥
Mater-
nal:
mater-
nal sep-
sis (sus-
Mater-
nal:
fever
(febrile
morbid-
Sub-
group
analyses
were car-
ried out
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given to
women
rou-
tinely
for pre-
venting
infec-
tion
at cae-
sarean
section
35 stud-
ies
included
in the re-
view but
only 31
provided
data
evi-
dence,
the bal-
ance of
benefits
and
harms
between
different
classes
of an-
tibiotic
given
prophy-
lacti-
cally to
women
under-
going
cae-
sarean
section
section,
both
elec-
tive and
non-
elective
2 antibi-
otics
from the
different
classes of
antibi-
otics)
pected
or
proven);
en-
dometri-
tis
Infant:
in-
fant sep-
sis (sus-
pected
or
proven);
oral
thrush
ity)
; wound
infec-
tion; uri-
nary
tract in-
fection;
thrush;
se-
rious in-
fectious
compli-
cation;
adverse
effects of
treat-
ment on
the
woman;
maternal
lengths
of hospi-
tal stay;
infec-
tions -
post-
hos-
pital dis-
charge
to
30 days
postop-
era-
tively;
readmis-
sions
Infant:
imme-
diate ad-
verse ef-
fects of
antibi-
otics on
by type
of
surgery;
by time
of
adminis-
tra-
tion; by
route of
adminis-
tration
Sensitiv-
ity anal-
ysis was
not per-
formed
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the in-
fant; in-
fant
length
of hospi-
tal stay;
long-
term ad-
verse ef-
fects;
infant’s
immune
system
develop-
ment
Addi-
tional
out-
comes:
develop-
ment
of bacte-
rial resis-
tance;
costs
CD006933
Gu-
rusamy
2011a
Meth-
ods of
decreas-
ing
infec-
tion to
improve
out-
comes
after
liver re-
sections
7 studies
(n =
521)
To de-
termine
the
benefits
and
harms of
different
inter-
ventions
in de-
creasing
the in-
fectious
compli-
cations
and im-
proving
the out-
comes
after
liver re-
section
People-
under-
going
liver re-
section
Antibi-
otics
Prebi-
otics
or probi-
otics
Im-
munomod-
ulation-
Topical
antibi-
otic or
antisep-
tic
No an-
tibi-
otics or
placebo;
no pro-
biotics
or probi-
otics or
placebo;
no im-
munomod-
ulation;
no
topical
antibi-
otic
or anti-
septic or
saline or
placebo
before
Mortal-
ity
Serious
adverse
events
Quality
of life
Hospital
stay
Number
of un-
planned
visits to
the doc-
tor
Return
to work
Costs
The unit
of anal-
ysis was
the
aggre-
gate data
on par-
ticipants
under-
going
liver re-
sec-
tion ac-
cording
to ran-
domised
group
Sensitiv-
ity anal-
ysis
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wound
closure;
another
of the in-
cluded
inter-
ventions
and sub-
group
anal-
ysis were
not con-
ducted
CD010268
Gu-
rusamy
2013a
Antibi-
otic pro-
phylaxis
for the
preven-
tion of
methi-
cillin-
resistant
Staphy-
lococcus
aureus
(MRSA)
related
com-
plica-
tions in
surgical
patients
12 stud-
ies
(n =
4704)
To com-
pare the
benefits
and
harms
of all
methods
of an-
tibiotic
prophy-
laxis
in the
preven-
tion of
postop-
erative
MRSA
infec-
tion and
related
compli-
cations
in peo-
ple un-
dergoing
surgery
People
under-
going
surgery,
irre-
spective
of age,
type of
surgery,
whether
surgery
was
elective
or emer-
gency,
and
whether
MRSA
coloni-
sation
was
identi-
fied by
routine
screen-
ing
Antibi-
otic pro-
phylaxis
Placebo
(or
no treat-
ment)
; differ-
ent an-
tibi-
otic pro-
phylaxis
(and reg-
imens)
All-
cause
mortal-
ity
Other
serious
adverse
events
Quality
of life
Total
length of
hospital
stay
Use
of health
care re-
sources
Rates of
SSIs
Rates of
SSIs due
to
MRSA
Rates
of infec-
tions
due to
MRSA
No sub-
group
anal-
ysis per-
formed.
Sensitiv-
ity anal-
ysis was
done
CD010365
Gu-
rusamy
2014a
Contin-
uous
versus
inter-
rupted
skin su-
tures for
non-
obstetric
surgery
5 studies
(n =
827)
To com-
pare the
benefits
and
harms
of con-
tinuous
com-
pared
with
inter-
rupted
skin
closure
People,
of any
age and
sex, un-
dergo-
ing non-
obstetric
surgery
Contin-
uous su-
tures
Inter-
rupted
sutures
SSI
Wound
dehis-
cence
Quality
of life
Hyper-
trophic
scarring
Keloid
scarring
Inci-
sional
hernia
Hospital
stay
Impact
to the
pa-
No sub-
group
anal-
ysis per-
formed;
sensitiv-
ity anal-
ysis was
done
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tech-
niques
in par-
ticipants
under-
going
non-
obstetric
surgery
tient and
to the
health-
care fun-
der
CD010425
Gu-
rusamy
2014b
Subcu-
taneous
clo-
sure ver-
sus no
subcuta-
neous
clo-
sure af-
ter non-
cae-
sarean
surgi-
cal pro-
cedures
6 studies
(n =
815)
8 studies
(n
= 1318)
included
in the re-
view but
only 6
con-
tributed
data
To com-
pare the
benefits
(such
as de-
creased
wound-
related
compli-
cations)
and
conse-
quences
(such
as in-
creased
oper-
ating
time) of
subcu-
taneous
closure
com-
pared
with no
subcu-
taneous
closure
in par-
ticipants
under-
going
non-cae-
sarean
surgical
proce-
dures
People,
of any
age and
sex, un-
dergoing
non-cae-
sarean
surgery
Subcu-
taneous
closure
No sub-
cuta-
neous
closure,
irrespec-
tive of
the su-
ture ma-
terial
SSI
Wound
dehis-
cence
Quality
of life
Hyper-
trophic
scarring
Keloid
scar-
ringIn-
cisional
hernia-
Hospital
stay-
Impact
to the
patient
and
to the
health-
care
funder
No sub-
group
anal-
ysis per-
formed;
sensitiv-
ity anal-
ysis was
done
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CD007892
Haas
2014
Vaginal
prepara-
tion
with an-
tisep-
tic solu-
tion be-
fore ce-
sarean
sec-
tion for
prevent-
ing post-
oper-
ative in-
fections
7 studies
(n
= 2816;
2635
anal-
ysed)
To de-
termine
if cleans-
ing the
vagina
with an
anti-
septic
solution
before
a cae-
sarean
delivery
de-
creases
the
risk of
maternal
infec-
tious
mor-
bidities,
includ-
ing en-
dometri-
tis and
wound
compli-
cations
Preg-
nant
women
who re-
ceived a
cae-
sarean
delivery
Vaginal
cleans-
ing with
any type
of anti-
septic
solution
Placebo
solu-
tion/
standard
care
Postpar-
tum en-
dometri-
tis
Wound
infec-
tion;
fever;
wound
seroma
or
hematoma
Com-
posite
wound
compli-
cations
Side ef-
fects of
vaginal
prepara-
tion
Sub-
group
anal-
ysis was
done
CD007462
Hadiati
2014
Skin
prepara-
tion for
prevent-
ing in-
fection
follow-
ing cae-
sarean
section
6 studies
(n =
1522)
To com-
pare the
effects of
different
agent
forms
and
methods
of pre-
opera-
tive skin
prepa-
ration
for pre-
venting
post cae-
sarean
infec-
Preg-
nant
women
under-
going
elective
or emer-
gency
cae-
sarean
section
Antisep-
tic
agents
used for
cae-
sarean
sec-
tion skin
prepara-
tion
Differ-
ent anti-
septic
agents,
forms or
methods
of appli-
cation
SSI
Metri-
tis or en-
dometri-
tis
Length
of stay
Mater-
nal mor-
tality
Repeat
surgery
Re-ad-
mission
resulting
from in-
fection
Reduc-
tion of
skin bac-
teria
colony
No sub-
group
anal-
ysis per-
formed;
sensitiv-
ity anal-
ysis was
not done
40Intraoperative interventions for preventing surgical site infection: an overview of Cochrane Reviews (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 2. Characteristics of included reviews (Continued)
tion count
Adverse
events
CD005360
Jones
2014a
Prophy-
lactic an-
tibiotics
to pre-
vent sur-
gical site
infec-
tion af-
ter
breast
cancer
surgery
11 stud-
ies
(n =
2867)
To de-
termine
the
effects of
prophy-
lactic
(pre- or
periop-
erative)
antibi-
otics on
the inci-
dence of
surgical
site in-
fection
(SSI)
after
breast
cancer
surgery
People
with
breast
cancer
under-
going
breast
surgery
with or
without
imme-
diate
recon-
struc-
tion as
part of
their
treat-
ment
Any pre-
or peri-
oper-
ative an-
tibi-
otic used
as pro-
phylaxis
where
there
was no
known
infec-
tion
No an-
tibiotic;
placebo;
another
antibi-
otic only
if there
was
a control
or
placebo
arm
SSI
Ad-
verse re-
actions
Death
Delay in
adjuvant
can-
cer treat-
ment be-
cause
of breast
wound
infec-
tion
Time to
wound
healing
Time
to infec-
tion
Read-
mission
to hospi-
tal
Cost of
care
(should
be a
compar-
ison be-
tween
the
treat-
ment
and con-
trol
group)
Sensitiv-
ity anal-
ysis
was per-
formed
CD006806
Kao
2009a
Peri-
oper-
ative gly-
caemic
con-
trol regi-
mens for
prevent-
ing sur-
gical site
5 studies
(n =
773)
To sum-
marise
the
evidence
for the
impact
of gly-
caemic
control
in the
People
aged ≥
18 years
, regard-
less of
diabetes
status,
who un-
derwent
a surgi-
1 gly-
caemic
control
regimen
At least
1 other
gly-
caemic
con-
trol regi-
men pre-
, intra-
, and/or
postop-
SSI Inci-
dence
and
severity
of hy-
pogly-
caemia
Level
of gly-
Sub-
group
analysis
was per-
formed
(people
with and
with-
out dia-
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infec-
tions in
adults
periop-
erative
period
on the
inci-
dence of
surgical
site in-
fections,
hypogly-
caemia,
level
of gly-
caemic
control,
all-cause
and in-
fection-
related
mortal-
ity, and
hospital
length of
stay and
to in-
vestigate
for dif-
ferences
of effect
between
different
levels
of gly-
caemic
control
cal pro-
cedure
eratively caemic
control
All-
cause
and in-
fection-
related
mortal-
ity
Length
of hospi-
tal stay
betes);
sensitiv-
ity anal-
yses were
not un-
dertaken
CD005571
Lipp
2013a
Systemic
antimi-
crobial
prophy-
laxis for
percuta-
neous
endo-
scopic
gastros-
tomy
13 stud-
ies
(n =
1637)
To
establish
whether
prophy-
lactic
use of
systemic
antimi-
crobials
reduces
the risk
of peri-
stomal
People
of any
age, gen-
der or
diagno-
sis, un-
dergoing
place-
ment
of a PEG
tube
Antimi-
cro-
bial pro-
phylaxis
Placebo
or usual
care and
compar-
isons be-
tween
differ-
ent an-
timicro-
bial regi-
mens
Peris-
tomal
site in-
fection
Identifi-
cation of
bacte-
ria caus-
ing in-
fection
Peritoni-
tis
Adverse
effects
Mortal-
ity Re-
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infec-
tion in
people
under-
going
place-
ment of
percu-
taneous
endo-
scopic
gastros-
tomy
tubes
moval of
PEG
tube be-
cause
of infec-
tion
Length
of hospi-
tal stay
CD005217
Low
2012a
Periop-
erative
antibi-
otics to
prevent
infec-
tion
after
first-
trimester
abortion
19 stud-
ies
(n =
9715)
To de-
termine:
1. the
effec-
tiveness
of an-
tibiotic
prophy-
laxis in
prevent-
ing post-
abortal
upper
genital
tract in-
fection;
2. the
most
effective
antibi-
otic
regimen;
3. the
most
effective
strategy
All
women
under-
going
induced
first
trimester
surgi-
cal or
medical
abortion
with or
without
a history
of pelvic
inflam-
matory
disease,
or a pre-
abortion
diagno-
sis of
bacterial
vagi-
nosis,
N. gon-
orrhoeae
or C.
tra-
choma-
tis
Any an-
tibiotic
regimen;
univer-
sal
antibi-
otic pro-
phylaxis
A
placebo
or noth-
ing; or
another
antibi-
otic
regimen;
a screen-
and-
treat
strategy
and/or
a com-
bina-
tion of
screen-
and-
treat and
antibi-
otic pro-
phylaxis
The pro-
portion
of
women
diag-
nosed
with
post-
abor-
tal upper
genital
tract in-
fection
Other
antibi-
otic
treat-
ments
provided
in the 6
weeks
follow-
ing the
abortion
Hospi-
talisa-
tion due
to infec-
tious
compli-
cations
Adverse
effects of
antibi-
otic pro-
phy-
laxis or
screen-
ing
Propor-
tion of
women
under-
Sub-
group
anal-
yses were
not per-
formed;
sensitiv-
ity anal-
yses were
not un-
dertaken
No data
of inter-
est to
overview
authors
reported
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going
the
screen-
and-
treat
strategy
who
were re-
infected
with
C. tra-
choma-
tis
CD003577
Mack-
een
2012
Tech-
niques
and ma-
terials
for skin
closure
in cae-
sarean
section
11 stud-
ies
(n =
1554)
To com-
pare the
effects of
skin clo-
sure
tech-
niques
and ma-
te-
rials on
mater-
nal out-
comes
and time
taken to
perform
a cae-
sarean
Women
under-
going a
cae-
sarean
Various
closure
tech-
niques
and ma-
terials
Differ-
ent clo-
sure
tech-
niques
and ma-
terials
Wound
infec-
tion
Wound
compli-
cations
Pres-
ence of
hematoma
Pres-
ence of
seroma
Skin
separa-
tion
Reclo-
sure
Read-
mission
Length
of stay
Pain per-
ception
Cosme-
sis
Pa-
tient sat-
isfaction
Length
of scar
Total
opera-
tive time
Cost
Only 8
(n
= 1166)
of the 11
included
tri-
als con-
tributed
data: 2
studies
did not
re-
port suf-
ficiently
on
prespec-
ified
out-
comes
on
which
this
review
was
focused;
and 1
study
did not
report
out-
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Mater-
nal
length of
hospital
stay
Pres-
ence of
hyper-
trophic
scar
comes
sepa-
rately
for
women
under-
go-
ing cae-
sarean.
Sub-
group
analysis
was per-
formed;
sensitiv-
ity anal-
ysis was
done too
CD009516
Mack-
een
2014a
Timing
of intra-
venous
prophy-
lactic
antibi-
otics
for pre-
venting
postpar-
tum in-
fectious
morbid-
ity in
women
under-
going
cesarean
delivery
10 stud-
ies
(n =
5041)
To com-
pare the
effects
of cae-
sarean
antibi-
otic pro-
phylaxis
admin-
istered
preoper-
atively
versus
after
neonatal
cord
clamp
on post-
opera-
tive in-
fectious
compli-
cations
for both
the
mother
and the
neonate
Preg-
nant
women
who
have un-
dergone
cae-
sarean
deliv-
ery and
received
prophy-
lactic an-
tibiotics
Prophy-
lactic in-
tra-
venous
(IV) an-
tibiotic
adminis-
tration
for cae-
sarean
birth 0-
30
and 30-
60 min-
utes
prior to
skin in-
cision
Prophy-
lactic an-
tibiotic
adminis-
tration
for cae-
sarean
birth af-
ter
neonatal
umbil-
ical cord
clamp-
ing
Com-
posite
maternal
postpar-
tum in-
fectious
morbid-
ity (in-
cluding
serious
infec-
tious
compli-
cations,
en-
domy-
ometri-
tis,
wound
infec-
tion, or
death at-
tributed
to
infec-
tion)
Mater-
nal mor-
tality
Mater-
nal post-
par-
tum in-
fection
Placen-
tal trans-
fer of an-
tibiotics
Breast-
feeding
Sub-
group
anal-
yses were
not per-
formed;
sensitiv-
ity anal-
yses were
not un-
dertaken
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Table 2. Characteristics of included reviews (Continued)
CD011876
Nabhan
2016a
Routes
of
adminis-
tration
of
antibi-
otic pro-
phylaxis
for pre-
venting
infec-
tion af-
ter cae-
sarean
section
10 stud-
ies
(n =
1354)
To assess
the
benefits
and
harms of
different
routes of
prophy-
lactic
antibi-
otics
given for
prevent-
ing in-
fectious
morbid-
ity in
women
under-
going
cae-
sarean
section
Women
under-
going
elective
or emer-
gency
cae-
sarean
section
Prophy-
lactic an-
tibi-
otic regi-
mens
Differ-
ent route
(s) of an-
tibiotic
adminis-
tration
Mater-
nal: en-
dometri-
tis;
wound
infec-
tion
Infant:
in-
fant sep-
sis (sus-
pected
or
proven)
Mater-
nal:
postpar-
tum
febrile
morbid-
ity; uri-
nary
tract in-
fection;
se-
rious in-
fectious
compli-
cation;
adverse
effects of
treat-
ment on
the
woman;
maternal
length of
hospital
stay;
readmis-
sions
Infant:
oral
thrush;
infant
length of
hospital
stay;
imme-
diate ad-
verse ef-
fects of
antibi-
otics on
the
infant
Com-
bined
groups
of simi-
lar
routes to
cre-
ate a sin-
gle pair-
wise
compar-
ison
Sub-
group
analysis
was car-
ried out
by
dosage;
Sensitiv-
ity anal-
ysis
was per-
formed
CD001181
Nelson
2014a
Antimi-
cro-
bial pro-
phylaxis
for col-
orectal
260 tri-
als
(n = 43,
451)
68
differ-
To
establish
the ef-
fective-
ness of
antimi-
Patients
(adults
and chil-
dren)
under-
going
All
antimi-
crobial
prophy-
laxis reg-
imens
No
treat-
ment
control/
placebo
Regi-
SSI (ab-
dominal
wound)
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Table 2. Characteristics of included reviews (Continued)
surgery ent an-
tibiotics
crobial
prophy-
laxis
for the
preven-
tion of
surgical
wound
infec-
tion in
people
under-
going
col-
orectal
surgery
either
elective
or emer-
gency
col-
orectal
surgery,
in which
sepsis
was not
sus-
pected
preoper-
atively
deliv-
ered
orally,
intra-
venously
or by in-
tramus-
cular
injection
used to
prevent
postop-
erative
infec-
tion
men dif-
fering in
dura-
tion,
tim-
ing, use
of aero-
bic/
anaer-
obic cov-
erage,
route of
adminis-
tration
A pub-
lished
gold
standard
regimen
CD005265
Sanabria
2010a
Antibi-
otic pro-
phy-
laxis for
patients
under-
going
elective
laparo-
scopic
chole-
cystec-
tomy
11 stud-
ies
(n =
1664)
To assess
the ben-
eficial
and
harmful
effects of
antibi-
otic pro-
phylaxis
versus
placebo
or no
prophy-
laxis for
people
under-
going
elective
laparo-
scopic
chole-
cystec-
tomy
Adult
patients
(> 17
years)
under-
going
laparo-
scopic
chole-
cystec-
tomy
with
preop-
erative
clinical
diagno-
sis of
cholelithi-
asis
without
acute
chole-
cystitis
or other
benign,
non-
acute
Antibi-
otic pro-
phylaxis,
adminis-
tered in-
tra-
venously
or orally,
prior to
elective
laparo-
scopic
surgery
Placebo
or no an-
tibiotic
All-
cause
mortal-
ity
SSI
Extra-
abdom-
inal in-
fections
Adverse
events
Quality
of life
A sensi-
tivity
analy-
sis using
worst-
best case
and
best-
worst
case
analyses
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Table 2. Characteristics of included reviews (Continued)
inflam-
matory
disease
of the
gall-
bladder.
Jaun-
diced
patients
were
excluded
CD003769
Sanchez-
Manuel
2012a
Antibi-
otic pro-
phy-
laxis for
hernia
repair
17 stud-
ies
(n =
7843)
To clar-
ify the
effec-
tiveness
of an-
tibiotic
prophy-
laxis in
reducing
postop-
erative
wound
infec-
tion
rates in
elective
open
inguinal
hernia
repair
Adult
patients
under-
going
open
elective
inguinal
or
femoral
hernia
repair,
with or
without
the use
of pros-
thetic
material
Admin-
istration
of
prophy-
lactic an-
tibiotics
Placebo
or
no treat-
ment
Wound
infec-
tion rate
assessed
at least at
30 days
after the
prophy-
lactic an-
tibiotic
treat-
ment
was
given
Sensitiv-
ity anal-
ysis
and sub-
group
anal-
ysis were
con-
ducted
CD007482
Smaill
2014a
Antibi-
otic pro-
phy-
laxis ver-
sus no
prophy-
laxis for
prevent-
ing in-
fection
after ce-
sarean
section
95 stud-
ies
(> 15,
000
women)
To assess
the
effects of
prophy-
lactic
antibi-
otics
com-
pared
with no
prophy-
lactic
antibi-
otics on
infec-
tious
Women
under-
going
cae-
sarean
section,
both
elective
(planned)
and
non-
elective/
emer-
gency
Any pro-
phy-
lactic an-
tibi-
otic regi-
men ad-
minis-
tered for
cae-
sarean
section
Placebo
or
no treat-
ment
Mater-
nal:
febrile
morbid-
ity;
wound
infec-
tion; en-
dometri-
tis;
se-
rious in-
fectious
compli-
cation
Mater-
nal:
urinary
tract in-
fection;
adverse
effects of
treat-
ment on
the
woman;
length of
stay in
hospital
A sen-
sitivity
analysis
was un-
dertaken
on the
primary
out-
comes
by study
quality,
omitting
the 9
quasi-
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Table 2. Characteristics of included reviews (Continued)
com-
plica-
tions in
women
under-
going
cae-
sarean
section
Infant:
imme-
diate ad-
verse ef-
fects of
antibi-
otics on
the in-
fant; oral
thrush
Infant:
length of
stay in
hospital;
long-
term ad-
verse ef-
fects;
immune
system
develop-
ment
Addi-
tional
out-
comes:
develop-
ment
of bacte-
rial resis-
tance;
cost
RCTs;
sub-
group
analyses
were
carried
out
by an-
tibiotic
regimen,
type of
surgery
and time
of
adminis-
tration
CD003087
Tanner
2006
Dou-
ble glov-
ing to re-
duce
surgical
cross-in-
fection
31 stud-
ies
(n
= not re-
ported)
Unit
of anal-
ysis var-
ied,
gloves
were col-
lected)
To de-
termine
if addi-
tional
glove
pro-
tection
reduces
the
num-
ber of
surgical
site or
blood-
borne
infec-
tions in
patients
or the
surgical
team;
to de-
termine
if addi-
tional
All
mem-
bers of
the sur-
gi-
cal team
prac-
tising in
a desig-
nated
surgical
theatre
Single
gloves
Double
gloves
Glove
liners
Coloured
perfora-
tion in-
dicator
systems
Cloth
outer
gloves
Steel
outer
gloves
Triple
gloves
An-
other/
different
type
Rates
of SSI in
surgical
patients
Rates
of perfo-
rations
in inner-
most
surgical
gloves
Rates of
blood-
borne
infec-
tions
in post-
oper-
ative pa-
tients or
the sur-
gical
team
2 tri-
als were
found
that ad-
dressed
sur-
gical site
infec-
tions in
patients.
Both tri-
als
reported
no infec-
tions
No sub-
group
anal-
ysis per-
formed;
sensitiv-
ity anal-
ysis was
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Table 2. Characteristics of included reviews (Continued)
glove
pro-
tection
reduces
the
number
of perfo-
rations
to the
inner-
most
pair of
surgical
gloves
not done
CD002929
Vincent
2016
Dispos-
able sur-
gical face
masks
for pre-
venting
surgical
wound
infec-
tion
in clean
surgery
3 studies
(n =
2106)
To de-
termine
whether
the
wearing
of dis-
posable
surgical
face
masks
by the
surgical
team
during
clean
surgery
reduces
postop-
erative
surgical
wound
infec-
tion
Adults
and chil-
dren un-
dergo-
ing clean
surgery
The
wearing,
by the
surgical
team
(scrubbed
and not
scrubbed)
, of dis-
posable
surgical
face
masks
No
masks
The in-
cidence
of post-
opera-
tive sur-
gical
wound
infec-
tion
Costs
Length
of hospi-
tal stay
Mortal-
ity rate
No sub-
group
anal-
ysis per-
formed
CD006353
Webster
2015
Use
of plastic
adhesive
drapes
during
surgery
for pre-
vent-
ing sur-
gical site
7 studies
(n =
4195)
To assess
the
effect of
adhesive
drapes
used
during
surgery
on
surgical
People
of
any age
or gen-
der, un-
dergoing
any type
of inpa-
tient or
outpa-
Plastic
adhesive
drapes
through
which
an
incision
is made
(used
alone or
No plas-
tic adhe-
sive
drapes;
other
drapes
(e.g. wo-
ven (ma-
terial) or
dispos-
SSI Mortal-
ity
Length
of hospi-
tal stay
Costs
Hospi-
tal read-
missions
The
only
sub-
group
analysis
that was
possible,
based on
available
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Table 2. Characteristics of included reviews (Continued)
infec-
tion
site in-
fection,
cost,
mortal-
ity and
morbid-
ity
tient
surgery
in com-
bination
with
other
drapes
and any
antisep-
tic skin
prepara-
tion)
able (pa-
per)
drapes)
Ad-
verse re-
actions
Other
se-
rious in-
fection
or infec-
tious
compli-
cation
such
as septi-
caemia
or septic
shock
data,
was of
clean
com-
pared
with
contam-
inated
surgery
(wound
classifi-
cation)
Sensi-
tivity
analyses
were
carried
out by
exclud-
ing trials
most
suscep-
tible
to bias:
those
with
inade-
quate al-
location
conceal-
ment
and un-
certain
or un-
blinded
outcome
assess-
ment
It was
not pos-
sible to
under-
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Table 2. Characteristics of included reviews (Continued)
take a
planned
sensi-
tivity
analysis
based
on the
type of
material
the
drape
was
made
from
due to
insuf-
ficient
detail
about
the
products
CD008884
Wetter-
slev
2015a
The ef-
fects of
high pe-
rioper-
ative in-
spira-
tory oxy-
gen frac-
tion
for adult
surgical
patients
28 stud-
ies
(n =
9330)
To assess
the
benefits
and
harms of
an FIO2
≥ 60%
com-
pared
with a
control
FIO2
≤ 40%
in the
periop-
erative
setting
in terms
of mor-
tality,
surgical
site in-
fection,
respi-
ratory
insuffi-
Sur-
gical pa-
tients ≥
18 years
who
were un-
dergoing
elective
or emer-
gency
surgery
A high
FIO2 of
≥ 60%
A
control
FIO2 of
≤ 40%
All-
cause
mortal-
ity
SSI
within
30 days
of
follow-
up after
surgery
All-
cause
mortal-
ity
within
30 days
of fol-
low-up
Respira-
tory in-
suffi-
ciency
Serious
adverse
event
Du-
ration of
postop-
erative
hospital-
isations
Qual-
ity of life
as mea-
Sub-
group
and sen-
sitivity
analyses
were
con-
ducted,
the role
of bias
was ex-
amined
and
trial se-
quential
analysis
(TSA)
was
applied
to exam-
ine the
level of
evidence
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Table 2. Characteristics of included reviews (Continued)
ciency,
serious
adverse
events
and
length
of stay
during
the
index
admis-
sion for
adult
surgical
patients
sured by
the
included
trials
support-
ing or
refuting
a high
FIO2
during
surgery,
anaes-
thesia
and
recovery
CD008062
Wood
2016 Cyanoacry-
late mi-
crobial
sealants
for skin
prepa-
ration
prior to
surgery
7 studies
(n =
859)
To assess
the
effects
of the
preoper-
ative ap-
plication
of mi-
crobial
sealants
(com-
pared
with
no mi-
crobial
sealant)
on rates
of SSI in
people
under-
going
clean
surgery
Partici-
pants
under-
going
any type
of clean
surgery
in an op-
erating
theatre
Micro-
bial
sealant
ap-
plied to
the sur-
gical in-
ci-
sion site
immedi-
ately be-
fore
surgery
No ap-
plication
of mi-
crobial
sealant,
with or
without
the use
of tra-
ditional
preop-
erative
prepara-
tion so-
lutions
such as
povi-
done io-
dine or
chlorhex-
idine
Rates of
SSI
All-
cause
mortal-
ity
Ad-
verse re-
actions
Other
se-
rious in-
fection
or infec-
tious
compli-
cation
Length
of hospi-
tal stay
Rates
of hospi-
tal re-ad-
missions
Costs
Postop-
erative
antibi-
otic use
No sub-
group
nor sen-
sitiv-
ity anal-
ysis was
not done
aThis is a multi-stage review. We only extracted data from trials delivering interventions that started in the intraoperative phase
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Table 3. Characteristics of excluded reviews
First review
author + year
Reasons for exclusion
Cirocchi 2014 Protocol
McCallum 2016 Protocol
Ousey 2016 Protocol
Smith 2016 Protocol (ongoing)
Verschuur 2004 Only included pre- and postoperative stages
Table 4. Assessment of results by ROBIS (risk of bias in systematic reviews)
Review title Phase 2
(identifying concerns with the review process)
Phase 3
(forming an overall
judgement of the
risk of bias)
Study eligibility
criteria
Identification and
selection of studies
Data collec-
tion and study ap-
praisal
Synthesis and find-
ings
Risk of bias in the
review
Healing by primary
versus secondary in-
tention after surgi-
cal treatment for pi-
lonidal sinus (AL-
Khamis 2010)
Staples versus su-
tures for closing leg
wounds after vein
graft harvesting for
coronary artery by-
pass surgery
(Biancari 2010)
Perioperative gly-
caemic control for
diabetic patients un-
dergoing surgery (
Buchleitner 2012)
Warming of intra-
venous and irriga-
tion fluids for pre-
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Table 4. Assessment of results by ROBIS (risk of bias in systematic reviews) (Continued)
venting inadvertent
periop-
erative hypothermia
(Campbell 2015)
Scalpel versus elec-
trosurgery for ab-
dominal incisions (
Charoenkwan
2017)
Scalpel versus no-
scalpel incision for
vasectomy (Cook
2014)
? ?
Tissue adhesives for
closure of surgical
incisions (Dumville
2014)
Preop-
erative skin antisep-
tics for preventing
surgical wound in-
fections after clean
surgery (Dumville
2015)
Pe-
rioperative increase
in global blood flow
to explicit defined
goals and outcomes
following surgery (
Grocott 2012)
Different classes of
antibiotics given to
women rou-
tinely for prevent-
ing infection at cae-
sarean section (Gyte
2014)
Methods of decreas-
ing infection to im-
prove outcomes af-
ter liver resections (
55Intraoperative interventions for preventing surgical site infection: an overview of Cochrane Reviews (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 4. Assessment of results by ROBIS (risk of bias in systematic reviews) (Continued)
Gurusamy 2011)
An-
tibiotic prophylaxis
for the prevention
of methicillin resis-
tant Staphylococcus
aureus (MRSA) re-
lated complications
in surgical patients
(Gurusamy 2013)
Continuous versus
interrupted skin su-
tures for non-
obstetric surgery (
Gurusamy 2014a)
Subcutaneous clo-
sure versus no sub-
cutaneous clo-
sure after non-cae-
sarean surgical pro-
cedures (Gurusamy
2014b)
Vaginal preparation
with antiseptic so-
lution before ce-
sarean section for
preventing postop-
erative infections (
Haas 2014)
Skin preparation for
preventing infection
following caesarean
section (Hadiati
2014)
Prophylactic antibi-
otics to prevent sur-
gical site infec-
tion after breast can-
cer surgery (Jones
2014)
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Table 4. Assessment of results by ROBIS (risk of bias in systematic reviews) (Continued)
Peri-operative gly-
caemic control reg-
imens for prevent-
ing surgical site in-
fections in adults (
Kao 2009)
Systemic antimicro-
bial prophylaxis for
percutaneous endo-
scopic gastrostomy (
Lipp 2013)
Perioperative antibi-
otics to prevent in-
fection after first-
trimester abortion (
Low 2012)
?
Techniques and ma-
terials for skin clo-
sure in caesarean
section (Mackeen
2012)
Tim-
ing of intravenous
prophylactic antibi-
otics for prevent-
ing postpartum in-
fectious morbidity
in women undergo-
ing cesareandelivery
(Mackeen 2014)
Routes of adminis-
tration of antibiotic
prophylaxis for pre-
venting infection af-
ter caesarean section
(Nabhan 2016)
Antimicrobial pro-
phylaxis for colorec-
tal surgery (Nelson
2014)
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Table 4. Assessment of results by ROBIS (risk of bias in systematic reviews) (Continued)
Antibiotic pro-
phylaxis for patients
undergoing elective
laparoscopic chole-
cystectomy
(Sanabria 2010)
Antibiotic
prophylaxis for her-
nia repair (Sanchez-
Manuel 2012)
? ?
Antibiotic pro-
phylaxis versus no
prophylaxis for pre-
venting infection af-
ter cesarean section
(Smaill 2014)
Double glov-
ing to reduce sur-
gical cross-infection
(Tanner 2006)
?
Disposable
surgical face masks
for preventing sur-
gical wound infec-
tion in clean surgery
(Vincent 2016)
Use of plastic ad-
hesive drapes dur-
ing surgery for pre-
venting surgical site
infection (Webster
2015)
The effects of high
perioperative inspi-
ratory oxygen frac-
tion for adult surgi-
cal patients
(Wetterslev 2015)
Cyanoacrylate mi-
crobial sealants for
skin prepara-
tion prior to surgery
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Table 4. Assessment of results by ROBIS (risk of bias in systematic reviews) (Continued)
(Wood 2016)
= low risk; = high risk; and ? = unclear risk
Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs)
Inter-
vention
and
com-
parison
inter-
vention
Meta-analysis results Narrative results Com-
ments
†meta-
analysis
by
overview
author
Odd
Ratio
(OR)
Illustrative com-
parative risks
(95% CI)
CI = confidence
interval
Risk
Ratio
(RR)
(95%
CI)
# ran-
dom-
effects,
all other
RR
= fixed-
effect
Num-
ber of
partici-
pants
(stud-
ies)
Qual-
ity/cer-
tainty
of the
evi-
dence
(GRADE)
* as-
sessed
by
overview
authors
§
assessed
by
review
authors
GRADE
Foot-
note
Re-
ported
out-
come
values
Re-
sults in
brack-
ets
are RR
with
95%
CIs un-
less
other-
wise in-
dicated
# ran-
dom-
effects,
all other
RR
= fixed-
effect
Num-
ber of
partici-
pants
(stud-
ies)
Qual-
ity/cer-
tainty
of the
evi-
dence
(GRADE)
* as-
sessed
by
overview
authors
Qual-
ity/cer-
tainty
of the
evi-
dence
(GRADE)
* as-
sessed
by
overview
authors
GRADE
Foot-
note
As-
sumed
risk
Corre-
spond-
ing risk
With
com-
parator
With
inter-
vention
1. Theatre staff attire
1.1.
Double
glov-
ing to
reduce
surgi-
cal
cross-
infec-
tion (
Tanner
2006)
Dou-
ble latex
versus
double
la-
tex with
0 per
1000
0 per
1000
(0 to 0)
Not es-
timable
125 (2) Low*1
1Downgraded
twice
due to
impre-
cision
(very
small
num-
bers of
partic-
ipants
with no
events)
N/A N/A N/A N/A Both
trials re-
ported
no SSI;
both
tri-
als were
under-
pow-
ered for
this
out-
come
59Intraoperative interventions for preventing surgical site infection: an overview of Cochrane Reviews (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
liner
1.2.
Dis-
pos-
able
surgi-
cal face
masks
for pre-
venting
sur-
gical
wound
infec-
tion in
clean
surgery
(
Vincent
2016)
Mask
ver-
sus no
mask
N/A N/A N/A N/A N/A N/A RR
0.10 (0.
01 to 1.
83);
RR
1.33 (0.
59 to 3.
02);
RR
1.16 (0.
73 to 1.
84)
2106
(3)
Low*1,2
1Downgraded
once
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
2Downgraded
due to
incon-
sistency
(direc-
tion of
inter-
vention
effect
varied
be-
tween
studies)
OR re-
ported
by
review
authors
and
con-
verted
to RR
by
overview
au-
thors:
OR
0.07 (0.
00 to 1.
63);
OR
1.34 (0.
58 to 3.
07);
OR
1.17 (0.
70 to 1.
97)
Data
not
pooled
ue
to clini-
cal het-
ero-
geneity
2. Preparation of the surgical site
2.1. Preoperative skin antiseptics for preventing surgical wound infections after clean surgery (Dumville 2015)
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
a)
2% io-
dine in
90% al-
cohol
versus
70% al-
cohol
13 per
1000
12 per
1000
(1 to
194)
RR 0.
94
(0.06 to
14.74)
157 (1) Very
low*1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
twice
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
N/A N/A N/A N/A
b) Povi-
done-
iodine
(PI)
paint
ver-
sus soap
scrub
and ap-
plica-
tion of
methy-
lated
spirit
51 per
1000
59 per
1000
(18 to
187)
RR
1.15 (0.
36 to 3.
66)
200 (1) Low*
1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
once
due to
impre-
cision
(small
num-
N/A N/A N/A N/A
61Intraoperative interventions for preventing surgical site infection: an overview of Cochrane Reviews (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
c-
1) 7.5%
aque-
ous PI
scrub/
10%
aque-
ous
PI paint
versus
10%
aque-
ous PI
paint
140 per
1000
106 per
1000
(48 to
236)
RR
0.76 (0.
34 to 1.
69)
178 (2) Low*
1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
once
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
N/A N/A N/A N/A
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
and
harm
for the
inter-
ven-
tion)
c-2)
7.5%
aque-
ous PI
scrub/
10%
aque-
ous PI
paint
versus
iodophor
in
alcohol
paint
41 per
1000
60 per
1000
(30 to
120)
RR
1.47 (0.
73 to 2.
94)
621 (6) Low*
1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
once
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
N/A N/A N/A N/A 2 stud-
ies
had no
events
in
either
group
(n =
160)
c-3)
10%
aque-
ous PI
paint
versus
iodophor
in
alcohol
20 per
1000
125 per
1000
(16 to
981)
RR 6.
25
(0.80 to
49.05)
106 (1) Low*1
1Downgraded
twice
due to
impre-
cision
(small
num-
N/A N/A N/A N/A
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
paint bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
d-1)
7.5%
aque-
ous PI
scrub/
10%
aque-
ous PI
paint
versus
2%
chlorhex-
idine
in 70%
alcohol
paint
N/A N/A N/A N/A N/A N/A N/A 100 (1) Very
low*1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
twice
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
Not es-
timable
due to
no re-
ported
SSI
events
in
either
group
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
of both
benefit
and
harm
for the
inter-
ven-
tion)
d-2)
10%
aque-
ous PI
paint
versus
2%
chlorhex-
idine
in 70%
alcohol
paint
63 per
1000
66 per
1000
(35 to
125)
RR
1.06 (0.
56 to 2.
00)
556 (1) Low*
1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
once
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
Not es-
timable
100 (1) N/A N/A No
events
in
either
group
d-3)
Iodophor
in
alcohol
(film-
form-
ing)
N/A N/A N/A N/A N/A N/A Not es-
timable
100 (1) Very
low*1,2 1Downgraded
once
due to
risk of
bias
No
events
in
either
group
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
paint
versus
2%
chlorhex-
idine
in 70%
alcohol
paint
2Downgraded
twice
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
d-4)
7.5%
aque-
ous PI
scrub
fol-
lowed
by 10%
aque-
ous PI
paint
versus
4%
chlorhex-
idine
in 70%
alcohol
scrub
21 per
1000
57 per
1000
(11 to
289)
RR 2.
76
(0.55 to
13.86)
183 (1) Low*
1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
once
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
Not es-
timable
127 (1) N/A N/A No
events
in
either
group
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
d-5)
0.5%
chlorhex-
idine in
methy-
lated
spirit
versus
PI paint
133 per
1000
62 per
1000
(36 to
109)
RR
0.47 (0.
27 to 0.
82)
542 (1) Low*
1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
once
due to
impre-
cision
(small
num-
bers of
events)
N/A N/A N/A N/A
e) 0.
75%
Cholorhex-
idine
and
1.5%
cetrim-
ide
scrub
versus
0.75%
chlorhex-
idine
and
1.5%
cetrim-
ide
paint
44 per
1000
44 per
1000
(6 to
296)
RR
0.98 (0.
14 to 6.
65)
91 (1) Low*
1,2
1
Down-
graded
once
due to
risk of
bias
2
Down-
graded
once
due to
impre-
cision
(small
num-
bers of
N/A N/A N/A N/A
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
f ) Alco-
holic
solu-
tions
versus
aque-
ous so-
lutions
53 per
1000
41 per
1000
(27 to
62)
RR
0.77 (0.
51 to 1.
17)
1400
(6)
Low*
1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
once
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
N/A N/A N/A N/A
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
harm
for the
inter-
ven-
tion)
2.2. Skin preparation for preventing infection following caesarean section (Hadiati 2014)
a)
. Drape
ver-
sus no
drape
112 per
1000
144 per
1000
(109 to
191)
RR
1.29 (0.
97 to 1.
71)
1294
(2)
Low§ §Wide
confi-
dence
interval
cross-
ing
the line
of no ef-
fect.
N/A N/A N/A N/A
b) 1-
minute
alcohol
scrub
with
iodophor
drape
versus
5-
minute
iodophor
scrub
without
drape
N/A N/A N/A N/A N/A N/A Not es-
timable
79 (1) Low*
1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
once
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
No
events
in
either
group
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
and
harm
for the
inter-
ven-
tion)
c)
Parachlorometaxylenol
with
iodine
versus
iodine
alone
120 per
1000
40 per
1000
(5 to
359)
RR
0.33 (0.
04 to 2.
99)
50 (1) Low§ §Wide
confi-
dence
interval
cross-
ing
the line
of no ef-
fect
& small
sample
size
N/A N/A N/A N/A
d)
Chlorhex-
idine
glu-
conate
versus
povi-
done
iodine
45 per
1000
95 per
1000
(9 to
974)
RR 2.
10
(0.20 to
21.42)
43 (1) Very
low§
§One
study
with
design
limita-
tions
Wide
confi-
dence
interval
cross-
ing
the line
of no ef-
fect,
few
events
& small
sample
size
N/A N/A N/A N/A
2.3.
Vaginal
prepa-
ration
with
anti-
septic
solu-
tion
33 per
1000
29 per
1000
(18 to
45)
RR
0.86 (0.
54 to 1.
36)
2205
(6)
Low§ §Most
stud-
ies con-
tribut-
ing data
had de-
sign
limita-
N/A N/A N/A N/A
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
before
ce-
sarean
section
for pre-
venting
post-
oper-
ative
infec-
tions
(Haas
2014)
Vaginal
prepa-
ration
versus
control
tions
Wide
confi-
dence
interval
cross-
ing
the line
of no ef-
fect
2.4. Use of plastic adhesive drapes during surgery for preventing surgical site infection (Webster 2015)
a) Ad-
hesive
drapes
versus
no ad-
hesive
drapes
112 per
1000
138 per
1000
(114 to
166)
RR
1.23 (1.
02 to 1.
48)
3082
(5)
High§ §The
total
sample
met
require-
ments
for
optimal
infor-
mation
size,
and the
total
number
of
events
ex-
ceeded
300
N/A N/A N/A N/A
b)
Iodine-
impreg-
nated
adhe-
sive
drapes
versus
no ad-
65 per
1000
67 per
1000
(43 to
104)
RR
1.03 (0.
66 to 1.
60)
1113
(2)
Moder-
ate§
§There
was
impre-
cision
on at
least 2
counts;
the
N/A N/A N/A N/A
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
hesive
drapes
total
sample
size
was too
small
to meet
optimal
infor-
mation
size,
and the
total
number
of
events
was less
than
300
2.5.
Cyanoacry-
late
micro-
bial
sealants
for
skin
prepa-
ration
prior
to
surgery
(Wood
2016)
Micro-
bial
sealant
versus
no mi-
crobial
sealant
111 per
1000
59 per
1000
(27 to
130)
RR
0.53 (0.
24 to 1.
18)#
859 (7) Low*
1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
once
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
N/A N/A N/A N/A One
study
had no
events
in
either
group
(n = 96)
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
harm
for the
inter-
ven-
tion)
3. Making the surgical incision
3.1.
Scalpel
versus
electro-
surgery
for ma-
jor ab-
dom-
inal in-
ci-
sions (
Charoenkwan
2017)
Electro-
surgery
versus
scalpel
74 per
1000
79 per
1000
(55 to
114)
RR 1.
07
(0.74 to
1.54)
2178
(11)
Low§
§Serious
limi-
tation
due to
lack of
infor-
mation
on ran-
domi-
sation
and
allo-
cation
con-
ceal-
ment
in three
studies
con-
tribut-
ing
more
than
50%
to the
analysis
Serious
impre-
cision
as 95%
CIs
around
the es-
timate
were
wide
ranging
N/A N/A N/A N/A
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
includ-
ing the
prob-
ability
of a re-
duction
as well
as an
increase
in
wound
infec-
tion
3.2.
Scalpel
ver-
sus no-
scalpel
inci-
sion for
vasec-
tomy (
Cook
2014)
No-
scalpel
versus
stan-
dard in-
cision
22 per
1000
7 per
1000
(2 to
21)
RR
0.31 (0.
10 to 0.
94)
1182
(2)
Very
Low*
1,2,3
1Downgraded
once
due to
risk of
bias
2Downgraded
once
due to
impre-
cision
(small
num-
bers of
events)
3Downgraded
once
due to
hetero-
geneity
N/A N/A N/A N/A 2
studies
differed
in their
timing
and
nature
of
postop-
erative
evalu-
ations,
includ-
ing the
evalua-
tion of
steril-
ity; and
in op-
erator
expe-
rience
with
the no-
scalpel
tech-
nique
Peto
OR re-
ported
74Intraoperative interventions for preventing surgical site infection: an overview of Cochrane Reviews (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
by
review
authors
and
con-
verted
to RR
by
overview
au-
thors:
Peto
OR
0.34 (0.
13 to 0.
90)
4. Treatment of patient during surgery
4.1.
Warm-
ing of
intra-
venous
and
irriga-
tion
fluids
for pre-
venting
inad-
vertent
periop-
erative
hy-
pother-
mia (
Camp-
bell
2015)
N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A No
SSI data
pro-
vided
4.2.
Periop-
erative
gly-
caemic
control
for di-
abetic
N/A N/A N/A N/A N/A N/A 1/10 vs.
6/22:
RR
0.37 (0.
05, 2.
66)#
32 (1) Very
low*1,2 1Downgraded
twice
due to
impre-
cision
(small
Only 2
in-
cluded
tri-
als were
cate-
gorised
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
pa-
tients
under-
going
surgery
(
Buch-
leitner
2012)
Inten-
sive ver-
sus con-
ven-
tional
gly-
caemic
control
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
2Downgraded
due to
incon-
sistency
(direc-
tion of
inter-
vention
effect
varied
be-
tween
studies)
in
intraop
phase;
Out-
come
for In-
fectious
compli-
cations
rather
than
SSIs
RR
0.71 (0.
22 to 2.
26)†
3/37 vs.
1/
36; RR
2.92 (0.
32, 26.
77)#
73 (1)
4.3. Peri-operative glycaemic control regimens for preventing surgical site infections in adults (Kao 2009)
a)
Intra-
and
postop-
erative
strict
versus
conven-
tional
gly-
caemic
control
N/A N/A N/A N/A N/A N/A 1/40 vs.
2/
38; RR
0.48 (0.
04 to 5.
03)
78 (1) Low*1
1Downgraded
twice
due to
impre-
cision
(small
num-
bers of
events;
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
with
intra-
venous
insulin
wide
confi-
dence
interval
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
b) In-
traop-
erative
strict
versus
conven-
tional
gly-
caemic
control
with
insulin
infu-
sion
N/A N/A N/A N/A N/A N/A 6/
185 vs.
7/186;
RR
0.86 (0.
30 to 2.
52)
371 (1) Low*1
1Downgraded
twice
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
Out-
come
for deep
wound
infec-
tion
c)
Intra-
and
postop-
erative
N/A N/A N/A N/A N/A N/A 0/72 vs.
9/
68; RR
0.05 (0.
140 (1) Low*
1,2 1Downgraded
once
due to
Out-
come
for
pneu-
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
strict
gly-
caemic
control
with
intra-
venous
glucose
insulin-
potas-
sium
infu-
sion
(GIK)
versus
conven-
tional
gly-
caemic
control
with
subcu-
taneous
insulin
00 to 0.
84)
risk of
bias
2Downgraded
once
due to
impre-
cision
(small
num-
bers of
events;
small
sample
size)
mo-
nia and
wound
infec-
tions
4.4.
Periop-
erative
in-
crease
in
global
blood
flow to
explicit
defined
goals
and
out-
comes
fol-
lowing
surgery
(
Grocott
2012)
In-
creased
global
N/A N/A N/A N/A N/A N/A 4/50 vs.
5/50;
RR
0.80 (0.
23 to 2.
81)
100 (1) Low*1
1Downgraded
once
due to
impre-
cision
(small
sample
size)
2Downgraded
once
due to
incon-
sistency
RR
0.40 (0.
19 to 0.
82)†
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
blood
flow
versus
control
0/19 vs.
2/18;
RR
0.19 (0.
01 to 3.
71)
37 (1)
3/30 vs.
8/30:
RR
0.38 (0.
11 to 1.
28)
60 (1)
2/32 vs.
10/34;
RR
0.21 (0.
05 to 0.
90)
66 (1)
0/30 vs.
2/60;
RR
0.39 (0.
02 to 7.
95)
90 (1)
4.5.
The
effects
of high
periop-
erative
inspi-
ratory
oxygen
frac-
tion for
adult
surgi-
cal pa-
tients (
129 per
1000
112 per
1000
(92 to
138)
RR
0.87 (0.
71 to 1.
07)#
7219
(15)
Low*
1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
once
due to
hetero-
geneity
N/A N/A N/A N/A Review
authors
ob-
tained
data on
(SF)-36
from
the
Greif
1999
trial
through
Daniel
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
Wetter-
slev
2015)
60% to
90%
oxygen
versus
30% to
40%
oxy-
gen pe-
riopera-
tively
Sessler,
who
was
a co-
author
of this
trial
report
5. Use of antibiotics
5.1.
Antibi-
otic
pro-
phy-
laxis
versus
no pro-
phy-
laxis
for pre-
venting
infec-
tion
after
ce-
sarean
section
(intra
and
post)
(Smaill
2014)
Antibi-
otic ver-
sus no
antibi-
otics
89 per
1000
36 per
1000
(31 to
41)
RR
0.40 (0.
35 to 0.
46)#
14,407
(82)
Moder-
ate§
§ In
most
studies
the
assess-
ment of
bias was
judged
as
unclear.
In a
third of
studies
the
control
group
did
not re-
ceive a
placebo
and
lack of
blind-
ing
could
have
influ-
enced
the
assess-
ment
N/A N/A N/A N/A 2 stud-
ies
had no
event in
either
arm (n
= 182)
6 out of
82 were
quasi-
RCTs
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
of out-
comes.
In less
than
20% of
studies
was
there
an ad-
equate
descrip-
tion
of se-
quence
genera-
tion
RR
0.40 (0.
35 to 0.
46)#
12,669
(76)
N/A N/A N/A N/A N/A N/A Sensi-
tiv-
ity anal-
ysis ex-
cluded
the
6 quasi-
RCTs;
no fur-
ther de-
tails
avail-
able
5.2. Review: Different classes of antibiotics given to women routinely for preventing infection at caesarean section (Gyte 2014)
Cephalosporins versus penicillins - all women
a)
Single
cephalosporin
versus
single
peni-
cillin
33 per
1000
27 per
1000
(12 to
59)
RR
0.83 (0.
38 to 1.
81)#
1497
(9)
Low§ §Most
stud-
ies con-
tribut-
ing data
had de-
sign
limita-
tions.
Wide
confi-
dence
interval
cross-
N/A N/A N/A N/A
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
ing
the line
of no ef-
fect
& small
sample
size
b)
Single
cephalosporin
versus
peni-
cillin
drug
combi-
nation
33 per
1000
23 per
1000
(13 to
42)
RR
0.72 (0.
40 to 1.
30)#
1608
(7)
Low*
1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
once
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
N/A N/A N/A N/A
c)
Cephalosporin
drug
combi-
nation
versus
single
peni-
32 per
1000
65 per
1000
(14 to
311)
RR
2.02 (0.
42 to 9.
63)#
139 (1) Very
low*1,2 1Downgraded
once
due to
risk of
bias
N/A N/A N/A N/A
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
cillin 2Downgraded
twice
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
d)
Cephalosporin
drug
combi-
nation
versus
peni-
cillin
drug
combi-
nation
37 per
1000
46 per
1000
(16 to
133)
RR
1.23 (0.
42 to 3.
58)#
315 (2) Very
low*1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
twice
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
N/A N/A N/A N/A
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
5.3. Antibiotic prophylaxis for the prevention of methicillin-resistant Staphylococcus aureus (MRSA) related complications
in surgical patients (Gurusamy 2013)
a) Pe-
floxacin
versus
cefa-
zolin
and
oxacillin
(tibial
fracture
requir-
ing
external
fixa-
tion)
90 per
1000
67 per
1000
(39 to
115)
RR 0.
74
(0.43 to
1.28)
616 (1) Very
low§
§The
risk of
bias in
the trial
was
high
The
confi-
dence
inter-
vals
over-
lapped
1 and/
or 0.75
and 1.
25.
There
were
fewer
than
300
events
in total
in the
inter-
vention
and
control
groups
N/A N/A N/A N/A Overall
SSIs;
Group
1: intra
Group
2: intra
and
post
b) Er-
tapenem
15 per
1000
9 per
1000
RR
0.59 (0.
672 (1) Very
low*1,2 1Downgraded
N/A N/A N/A N/A MRSA
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
versus
cefote-
tan
(2 to
37)
14 to 2.
46)
once
due to
risk of
bias
2Downgraded
twice
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
SSIs;
over 30
min
within
60 min
prior to
the ini-
tial in-
cision
c)
Cefaman-
dole
versus
cefaman-
dole
and
gen-
tamycin
0 per
1000
0 per
1000
(0 to 0)
RR 5.
08
(0.24 to
105.24)
522 (1) Very
low*1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
twice
due to
impre-
cision
(small
num-
bers of
events;
N/A N/A N/A N/A Overall
SSIs
One
study
with 4
arms
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
d) Ce-
fazolin
and
gen-
tamycin
versus
cefaman-
dole
and
gen-
tamycin
0 per
1000
0 per
1000
(0 to 0)
RR 17.
67
(1.03 to
304.54)
516 (1) Very
low*1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
twice
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
N/A N/A N/A N/A
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
harm
for the
inter-
ven-
tion)
e) Ce-
fazolin
versus
cefaman-
dole
8 per
1000
27 per
1000
(6 to
131)
RR 3.
55
(0.75 to
16.95)
514 (1) Very
low*1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
twice
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
N/A N/A N/A N/A
f) Ce-
fazolin
versus
cefa-
zolin
and
gen-
tamycin
32 per
1000
28 per
1000
(10 to
75)
RR
0.87 (0.
32 to 2.
36)
508 (1) Very
low*1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
twice
N/A N/A N/A N/A
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
g) Co-
amoxi-
clav
or cefo-
taxime
versus
placebo
375 per
1000
98 per
1000
(41 to
244)
RR
0.26 (0.
11 to 0.
65)
99 (1) Low*1
1Downgraded
twice
due to
impre-
cision
(small
num-
bers of
events;
small
sample
size)
N/A N/A N/A N/A Overall
SSIs
h) Van-
comycin
and ce-
fazolin
versus
cefa-
zolin
(open
frac-
tures)
87 per
1000
87 per
1000
(23 to
327)
RR
1.00 (0.
27 to 3.
76)
92 (1) Very
low*1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
twice
due to
N/A N/A N/A N/A Overall
SSIs
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
i) Dap-
to-
mycin
and ce-
fazolin
ver-
sus ce-
fazolin
129 per
1000
39 per
1000
(9 to
177)
RR
0.30 (0.
07 to 1.
37)
113 (1) Very
low*1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
twice
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
N/A N/A N/A N/A Over-
all SSIs;
one
study
with 3
arms
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
j) Van-
comycin
and ce-
fazolin
versus
cefa-
zolin
(vas-
cular
surgery)
129 per
1000
125 per
1000
(49 to
323)
RR
0.97 (0.
38 to 2.
50)
118 (1) Very
low*1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
twice
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
N/A N/A N/A N/A
k) Van-
comycin
and ce-
fazolin
39 per
1000
125 per
1000
(27 to
575)
RR 3.
19
(0.69 to
14.65)
107 (1) Very
low*1,2 1Downgraded
once
N/A N/A N/A N/A
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
versus
dapto-
mycin
and ce-
fazolin
due to
risk of
bias
2Downgraded
twice
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
l) Van-
comycin
versus
ce-
furox-
ime
32 per
1000
34 per
1000
(17 to
70)
RR
1.08 (0.
53 to 2.
21)
884 (1) Low*
1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
once
due to
impre-
cision
(small
num-
bers of
events;
wide
N/A N/A N/A N/A
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
5.4. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery (Jones 2014)
a) Pre-
opera-
tive an-
tibiotic
versus
placebo
N/A N/A N/A N/A N/A N/A 3/69 vs
10/
72; RR
0.31 (0.
09 to 1.
09)
1708 (6) High* RR
0.74 (0.
56 to 0.
98)†
17/
110 vs
19/108;
RR
0.88 (0.
48 to 1.
60)
29/
164 vs
32/169;
RR
0.93 (0.
59 to 1.
47)
8/
144 vs
13/148;
RR
0.63 (0.
27 to 1.
48)
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
17/
303 vs
26/303;
RR
0.65 (0.
36 to 1.
18)
3/
59 vs 5/
59; RR
0.60 (0.
15 to 2.
40)
b) Pre-
opera-
tive an-
tibiotic
versus
none
N/A N/A N/A N/A N/A N/A 9/
187 vs
25/182;
RR
0.35 (0.
17 to 0.
73)
987 (2) Low*
1,2 1Downgraded
once
due to
impre-
cision
(small
num-
bers of
events)
2Downgraded
due to
incon-
sistency
(direc-
tion of
inter-
vention
effect
varied
be-
tween
studies)
RR
0.48 (0.
28 to 0.
82)†
10/
311 vs
14/307;
RR
0.71 (0.
32 to 1.
56)
c) Peri-
opera-
tive an-
tibi-
otics
versus
no an-
tibiotic
182 per
1000
20 per
1000
(2 to
355)
RR
0.11 (0.
01 to 1.
95)
44 (1) Very
low*1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
N/A N/A N/A N/A
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
twice
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
5.5.
Sys-
temic
antimi-
crobial
pro-
phy-
laxis
for per-
cuta-
neous
endo-
scopic
gas-
tros-
tomy
(Lipp
2013)
Sys-
temic
antibi-
otic
(IV)
versus
placebo/
no in-
terven-
tion/
skin an-
tiseptic
242 per
1000
94 per
1000
(73 to
123)
RR
0.39 (0.
30 to 0.
51)
1271
(12)
Low*1
1Downgraded
twice
due to
risk of
bias
N/A N/A N/A N/A OR re-
ported
by
review
authors
and
con-
verted
to RR
by
overview
au-
thors:
OR
0.36 (0.
26 to 0.
50)
5.6.
Timing
of
intra-
venous
pro-
phy-
lactic
antibi-
41 per
1000
24 per
1000
(17 to
33)
RR
0.59 (0.
44 to 0.
81)#
5041
(10)
High§ N/A N/A N/A N/A
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
otics
for pre-
venting
post-
partum
infec-
tious
mor-
bidity
in
women
under-
going
ce-
sarean
deliv-
ery (
Mack-
een
2014)
Pro-
phy-
lactic
intra-
venous
antibi-
otics
admin-
istered
before
ce-
sarean
incision
versus
after
neona-
tal um-
bilical
cord
clamp-
ing
(mater-
nal out-
comes)
5.7.
Routes
of ad-
minis-
21 per
1000
10 per
1000
(4 to
30)
RR
0.49 (0.
17 to 1.
43)#
859 (7) Very
low§ §Studies
with
design
N/A N/A N/A N/A Intra or
intra &
post
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
tration
of an-
tibiotic
pro-
phy-
laxis
for pre-
venting
infec-
tion
after
cae-
sarean
sec-
tion (
Nab-
han
2016)
Intra-
venous
(IV)
ver-
sus irri-
gation
limita-
tions
Studies
include
rela-
tively
few
patients
and few
events
and
have a
wide
95% CI
that in-
cludes
both
appre-
ciable
benefit
and
appre-
ciable
harm
5.8.
Antibi-
otic
pro-
phy-
laxis
for pa-
tients
under-
going
elective
laparo-
scopic
chole-
cystec-
tomy (
Sanabria
2010)
Antibi-
otic
pro-
phy-
laxis
33 per
1000
27 per
1000
(15 to
46)
RR
0.81 (0.
47 to 1.
42)#
1664
(11)
Very
low*1,2 1Downgraded
twice
due to
risk of
bias
2Downgraded
once
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
N/A N/A N/A N/A Intra or
intra &
post
OR re-
ported
by
review
authors
and
con-
verted
to RR
by
overview
au-
thors:
OR
0.87 (0.
49 to 1.
54)#
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
versus
placebo
or no-
pro-
phy-
laxis
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
5.
9. An-
tibiotic
pro-
phy-
laxis
for her-
nia
repair (
Sanchez-
Manuel
2012)
Antibi-
otic
pro-
phy-
laxis
versus
placebo
46 per
1000
31 per
1000
(25 to
38)
RR
0.67 (0.
54 to 0.
84)#
17
(7843)
Moder-
ate*1
1
Down-
graded
once
due to
risk of
bias
N/A N/A N/A N/A Intra or
intra &
post
OR re-
ported
by
review
authors
and
con-
verted
to RR
by
overview
au-
thors:
OR
0.64 (0.
50 to 0.
82)#
5.10. Antimicrobial prophylaxis for colorectal surgery (Nelson 2014)
a) An-
tibi-
otic ver-
sus no
antibi-
otic/
placebo
N/A N/A N/A N/A N/A N/A 5/49 vs
16/50;
RR
0.32 (0.
13 to 0.
80)#
405 (5) Low*
1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
once
due to
incon-
sistency
RR
0.25 (0.
16 to 0.
41)†
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
2/30 vs
11/27;
RR
0.16 (0.
04 to 0.
67)#
7/108
vs 8/49;
RR
0.40 (0.
15 to 1.
03)#
3/13 vs
11/19;
RR
0.40 (0.
14 to 1.
16)#
2/29 vs
12/31;
RR
0.18 (0.
04 to 0.
73)#
b) Du-
ration
of ther-
apy
(short-
term
versus
long-
term
dura-
tion an-
tibi-
otic)
N/A N/A N/A N/A N/A N/A 2/31 vs
0/27;
RR 4.
38
(0.22 to
87.32)#
1484 (7) Moder-
ate*1 1Downgraded
once
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
RR
1.05 (0.
78 to 1.
40)†
Short-
term:
partic-
ipants
who re-
ceived
only a
single
preop-
erative
dose;
long-
term:
those
98Intraoperative interventions for preventing surgical site infection: an overview of Cochrane Reviews (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
who re-
ceived
at
least a
second
intra-
oper-
ative
dose of
antibi-
otic or
postop-
erative
dosing
(or
both)
14/
100 vs
12/104;
RR
1.21 (0.
59 to 2.
49)#
9/
149 vs
8/145;
RR
1.09 (0.
43 to 2.
76)#
23/
113 vs
22/114;
RR
1.05 (0.
62 to 1.
78)#
8/65 vs
8/70;
RR
1.08 (0.
43 to 2.
70)#
5/71 vs
7/67;
RR
0.67 (0.
22 to 2.
02)#
22/
209 vs
23/219;
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
RR
1.00 (0.
58 to 1.
74)#
c) Addi-
tional
aerobic
cover-
age ver-
sus no
aero-
bic cov-
erage
N/A N/A N/A N/A N/A N/A 0/13 vs
3/11;
RR
0.12 (0.
01 to 2.
14)#
230 (4) Low*
1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
once
due to
impre-
cision
(small
num-
bers of
events)
RR
0.38 (0.
16 to 0.
96)†#
3/47 vs
0/50;
RR
7.44 (0.
39
to 140.
25)#
0/26 vs
6/23;
RR
0.07 (0.
00 to 1.
15)#
3/27 vs
7/33;
RR
0.52 (0.
15 to 1.
83)#
d) Ad-
ditional
anaero-
bic cov-
er-
age ver-
sus little
anaero-
bic cov-
erage
N/A N/A N/A N/A N/A N/A 19/
287 vs
44/280;
RR
0.42 (0.
25 to 0.
70)#
1098 (4) Low*
1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
once
due to
incon-
sistency
RR
0.65 (0.
47 to 0.
90)†#
18/
121 vs
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
16/116;
RR
1.08 (0.
58 to 2.
01)#
7/89 vs
9/85;
RR
0.74 (0.
29 to 1.
91)#
9/36 vs
17/84;
RR
1.24 (0.
61 to 2.
51)#
e) Oral
versus
intra-
venous
N/A N/A N/A N/A N/A N/A 2/35 vs
1/37;
RR 2.
11
(0.20 to
22.29)#
72 (1) Very
low*1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
twice
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
of both
benefit
and
harm
for the
inter-
ven-
tion)
f )
Com-
bined
oral and
intra-
venous
versus
oral or
intra-
venous
alone
N/A N/A N/A N/A N/A N/A 9/
169 vs
15/141;
RR
0.50 (0.
23 to 1.
11)#
310 (1) Low*
1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
once
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
5.11.
Meth-
ods
of de-
creas-
ing in-
fection
N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A No
SSI data
pro-
vided
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
to im-
prove
out-
comes
after
liver
resec-
tions (
Gu-
rusamy
2011)
5.12.
Periop-
erative
antibi-
otics to
prevent
infec-
tion
after
first-
trimester
abor-
tion
(Low
2012)
N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A No
SSI data
pro-
vided
6. Management of theatre traffic (no reviews)
7. Wound irrigation (no reviews)
8. Wound closure
8.1.
Con-
tin-
uous
versus
inter-
rupted
skin
sutures
for
non-
ob-
stetric
surgery
(
71 per
1000
52 per
1000
(29 to
95)
RR
0.73 (0.
40 to 1.
33)
602 (4) Very
low§
§High
risk of
bias;
the
confi-
dence
inter-
vals
over-
lapped
1 and
either
0.75 or
1.25, or
N/A N/A N/A N/A
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
Gu-
rusamy
2014a)
Con-
tinu-
ous ver-
sus in-
ter-
rupted
skin su-
tures
both.
The
number
of
events
in the
inter-
vention
and
control
group
was
fewer
than
300
8.2.
Sub-
cuta-
neous
closure
versus
no sub-
cuta-
neous
closure
after
non-
cae-
sarean
sur-
gical
proce-
dures (
Gu-
rusamy
2014b)
Subcu-
taneous
versus
no sub-
cuta-
neous
closure
84 per
1000
71 per
1000
(44 to
112)
RR
0.84 (0.
53 to 1.
33)
815 (6) Very
low§
§The
trial
(s) was
(were)
of high
risk of
bias
The
confi-
dence
inter-
vals
over-
lapped
1 and
either
0.75 or
1.25 or
both
The
number
of
events
in the
inter-
vention
and
control
group
was
fewer
than
300
N/A N/A N/A N/A
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
8.3. Review: Techniques and materials for skin closure in caesarean section (Mackeen 2012)
a)
Staples
versus
ab-
sorbable
subcu-
ticular
suture
31 per
1000
26 per
1000
(13 to
52)
RR
0.85 (0.
43 to 1.
71)
916 (6) Low*
1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
once
due to
incon-
sistency
(direc-
tion of
inter-
vention
effect
varied
be-
tween
studies)
N/A N/A N/A N/A
13 per
1000
10 per
1000
(2 to
40)
RR
0.72 (0.
17 to 3.
01)
400 (4) Low*
1,2 1Downgraded
once
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
N/A N/A N/A N/A Sensi-
tivity
anal-
ysis:
Staples
(1/177)
versus
ab-
sorbable
subcu-
ticular
suture
(3/223)
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
for the
inter-
ven-
tion)
2
Down-
graded
once
due to
incon-
sistency
(direc-
tion
of inter-
ven-
tion ef-
fect var-
ied be-
tween
studies)
b)
Barbed
suture
versus
PDS
suture
33 per
1000
31 per
1000
(6 to
167)
RR
0.96 (0.
18 to 5.
10)
188 (1) Low*1
1Downgraded
twice
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
N/A N/A N/A N/A
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
8.4. Healing by primary versus secondary intention after surgical treatment for pilonidal sinus (AL-Khamis 2010)
primary versus secondary intention
a)
Open
versus
closed
(all)
77 per
1000
100 per
1000
(71 to
142)
RR
1.31 (0.
93 to 1.
85)
1231
(10)
Very
low*
1,2,3
1Downgraded
once
due to
risk of
bias
2Downgraded
once
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
3Downgraded
once
due to
incon-
sistency
(direc-
tion of
inter-
N/A N/A N/A N/A
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
vention
effect
varied
be-
tween
studies)
b)
Closed
(mid-
line)
versus
closed
(other)
33 per
1000
124 per
1000
(62 to
246)
RR
3.72 (1.
86 to 7.
42)
541 (5) Low*
1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
once
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
N/A N/A N/A N/A 1 study
out of 5
had no
event in
both
arms
c) Clas-
sic Lim-
berg
versus
modi-
fied
Lim-
berg
30 per
1000
228 per
1000
(30 to
1000)
RR 7.
54
(1.00 to
57.07)
68 (1) Very
low*1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
N/A N/A N/A N/A
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
twice
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
d)
Kary-
dakis
ver-
sus clas-
sic Lim-
berg
80 per
1000
260 per
1000
(91 to
743)
RR
3.25 (1.
14 to 9.
29)
100 (1) Very
low*1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
twice
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
N/A N/A N/A N/A
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
8.5.
Staples
versus
sutures
for
closing
leg
wounds
after
vein
graft
har-
vesting
for
coro-
nary
artery
bypass
surgery
(
Bian-
cari
2010)
Staples
versus
sutures
80 per
1000
97 per
1000
(48 to
192)
RR
1.20 (0.
60 to 2.
39)
322 (3) Very
low*1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
twice
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
No sta-
tisti-
cally
signifi-
cant
differ-
ence: P
= 0.99
258 par-
ticipants with 516
leg segments
N/A N/A One
study
was ex-
cluded
from
the
pooled
analysis
due to
the risk
of a unit
of anal-
ysis er-
ror
8.6. Tissue adhesives for closure of surgical incisions (Dumville 2014)
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
a) Tis-
sue ad-
hesives
versus
sutures
23 per
1000
40 per
1000
(22 to
73)
RR
1.72 (0.
94 to 3.
16)
1239
(18)
Very
low§
§Study
95% CI
is wide;
Possi-
ble unit
of anal-
ysis is-
sues
N/A N/A N/A N/A Eight
studies
had no
events
in
either
group
(n =
495)
Sensi-
tiv-
ity anal-
ysis was
con-
ducted
due to
the unit
of anal-
ysis is-
sues in
3 stud-
ies;
show-
ing sim-
ilar re-
sults
b) Tis-
sue ad-
hesives
ver-
sus ad-
hesive
tape
43 per
1000
60 per
1000
(17 to
209)
RR
1.37 (0.
39 to 4.
81)#
190 (3) Low§ §Study
95%
CIs
are very
wide
Evi-
dence
of
incon-
sistency
in point
esti-
mates.
With
the
point
esti-
mate
from
one
N/A N/A N/A N/A
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
study
lying
outside
the
95%
CIs of
another
c) Tis-
sue ad-
hesives
versus
staples
71 per
1000
99 per
1000
(21 to
463)
RR
1.39 (0.
30 to 6.
54)#
320 (4) Very
low§
§Study
95%
CIs
are very
wide
Evi-
dence
of point
esti-
mates
lying in
oppo-
site di-
rections
with
the es-
timate
for one
study
lying
outside
the
95%
CI of
another
N/A N/A N/A N/A One
study
had no
events
in
either
group
(n = 70)
d) Tis-
sue ad-
hesives
versus
other
tech-
niques
66 per
1000
27 per
1000
(7 to
105)
RR
0.41 (0.
11 to 1.
60)#
249 (2) Low§ §Study
95%
CIs
are very
wide
Single
study
with
low
event
rate
N/A N/A N/A N/A One
study
had no
events
in
either
group
(n = 40)
e) Ad-
hesives
ver-
sus ad-
47 per
1000
38 per
1000
(7 to
200)
RR
0.82 (0.
16 to 4.
31)
148 (1) Very
low§
§Study
95%
CIs
N/A N/A N/A N/A
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Table 5. ’Summary of findings’ table - Outcome: Surgical Site Infections (SSIs) (Continued)
hesives:
high
viscos-
ity ver-
sus
low vis-
cosity
are very
wide
Single
study
with
low
event
rate
f ) Ad-
hesives
versus
adhe-
sives:
octyl-
cyanoacry-
late
versus
butyl-
cyanoacry-
late
333 per
1000
210 per
1000
(70 to
627)
RR
0.63 (0.
21 to 1.
88)
80 (2) Low§ §The
95% CI
esti-
mate
around
the RR
of 1.46
is very
wide
N/A N/A N/A N/A One
study
had no
events
in
either
group
(n = 43)
9. Theatre cleansing (no reviews)
Table 6. ’Summary of findings’ table - Outcome: Mortality
Inter-
vention
and
com-
parison
inter-
vention
Meta-analysis results Narrative results Com-
ments
† meta-
analysis
by
overview
au-
thorOdd
Ratio
(OR)
Illustrative com-
parative risks
(95% CI)
CI = confidence
interval
Risk
Ratio
(RR)
(95%
CI)
#random-
effects,
all
other
RR =
Num-
ber of
partici-
pants
(stud-
ies)
Qual-
ity/cer-
tainty
of the
evi-
dence
(GRADE)
* as-
sessed
by
overview
GRADE
Foot-
note
Re-
ported
out-
come
values
Re-
sults in
brack-
ets
are RR
Num-
ber of
partici-
pants
(stud-
ies)
Qual-
ity/cer-
tainty
of the
evi-
dence
(GRADE)
*as-
sessed
by
GRADE
Foot-
note
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Table 6. ’Summary of findings’ table - Outcome: Mortality (Continued)
fixed-
effect
authors
§
assessed
by
review
authors
with
95%
CIs un-
less
other-
wise in-
dicated
# ran-
dom-
effects,
all other
RR
= fixed-
effect
overview
authors
As-
sumed
risk
Corre-
spond-
ing risk
With
com-
parator
With
inter-
vention
4.2.
Periop-
erative
gly-
caemic
control
for di-
abetic
pa-
tients
under-
going
surgery
(
Buch-
leitner
2012)
Inten-
sive ver-
sus con-
ven-
tional
gly-
caemic
control
N/A N/A N/A N/A N/A N/A 0/10 vs.
2/22:
RR 0.
42
(0.02 to
7.99)#
32 (1) Very
low*1,2 1Downgraded
twice
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
RR
1.23 (0.
18 to 8.
43)†
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Table 6. ’Summary of findings’ table - Outcome: Mortality (Continued)
inter-
ven-
tion)
2Downgraded
once
due to
incon-
sistency
2/37 vs.
0/36:
RR 4.
87
(0.24 to
98.02)#
73 (1)
4.3. Peri-operative glycaemic control regimens for preventing surgical site infections in adults (Kao 2009)
Intra-
and
post-
oper-
ative
strict
versus
conven-
tional
gly-
caemic
control
with
intra-
venous
insulin
N/A N/A N/A N/A N/A N/A 6/40 vs.
7/38;
RR 0.
81
(0.30 to
2.20)
78 (1) Low*1
1Downgraded
twice
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
Intra-
oper-
ative
strict
N/A N/A N/A N/A N/A N/A 4/
185 vs.
0/186;
RR 9.
371 (1) Low*1
1Downgraded
twice
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Table 6. ’Summary of findings’ table - Outcome: Mortality (Continued)
versus
conven-
tional
gly-
caemic
control
with
insulin
infu-
sion
05
(0.49 to
166.88)
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
4.4.
Periop-
erative
in-
crease
in
global
blood
flow to
explicit
defined
goals
and
out-
comes
fol-
lowing
surgery
(
Grocott
2012)
In-
creased
global
66 per
1000
44 per
1000
(26 to
74)
RR
0.67 (0.
40 to 1.
13)
1202
(15)
Low*1 1
Down-
graded
twice
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
N/A N/A N/A N/A Time
inter-
vention
started -
Intra-
opera-
tive;
3 stud-
ies
have no
events
in
either
group
(n=
177)
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Table 6. ’Summary of findings’ table - Outcome: Mortality (Continued)
blood
flow
versus
control
and
harm
for the
inter-
ven-
tion)
4.5.
The
effects
of high
periop-
erative
inspi-
ratory
oxygen
frac-
tion for
adult
surgi-
cal pa-
tients (
Wetter-
slev
2015)
60% to
90%
oxygen
versus
30% to
40%
oxy-
gen pe-
riopera-
tively
164 per
1000
137 per
1000
(89 to
212)
RR
1.07 (0.
87 to 1.
33) #
4918
(8)
Low*
1,2
1
Down-
graded
once
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
2
Down-
graded
once
due to
hetero-
geneity
N/A N/A N/A N/A 2 stud-
ies
have no
events
in
either
group
(n=
393)
5.1. Antibiotic prophylaxis for the prevention of methicillin-resistant Staphylococcus aureus (MRSA) related com-
plications in surgical patients (Gurusamy 2013)
Co-
amoxi-
clav
146 per
1000
79 per
1000
(25 to
RR
0.54 (0.
17 to 1.
99 (1) Low*1
1Downgraded
twice
N/A N/A N/A N/A
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Table 6. ’Summary of findings’ table - Outcome: Mortality (Continued)
or cefo-
taxime
versus
placebo
251) 72) due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
Van-
comycin
versus
ce-
furox-
ime
2 per
1000
5 per
1000
(0 to
50)
RR 2.
02
(0.18 to
22.18)
884 (1) Very
low*1,2 1Downgraded
once
due to
risk of
bias
2Downgraded
twice
due to
impre-
cision
(small
num-
bers of
events;
wide
confi-
dence
inter-
vals
that
N/A N/A N/A N/A
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Table 6. ’Summary of findings’ table - Outcome: Mortality (Continued)
include
the pos-
sibility
of both
benefit
and
harm
for the
inter-
ven-
tion)
5.11. Methods of decreasing infection to improve outcomes after liver resections (Gurusamy 2011)
Long
dura-
tion an-
tibi-
otics
versus
short
dura-
tion an-
tibi-
otics
Not es-
timable
Not es-
timable
Not es-
timable
180 (1) Very
low§
§High
risk of
bias
The
number
of tri-
als were
too few
to assess
incon-
sistency
The
confi-
dence
inter-
vals of
risk ra-
tio
over-
lapped
0.
75 and
1.25
Publi-
cation
bias
could
not be
assessed
be-
cause of
the few
trials
N/A N/A N/A N/A Not es-
timable
due to
no
event in
either
group
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Table 6. ’Summary of findings’ table - Outcome: Mortality (Continued)
Topical
povi-
done
iodine
gel ver-
sus no
topical
povi-
done
iodine
gel
71 per
1000
96 per
1000
(17 to
538)
RR
1.35 (0.
24 to 7.
53)
59 (1) Very
low§
§High
risk of
bias
The
number
of tri-
als were
too few
to assess
incon-
sistency
The
confi-
dence
inter-
vals of
risk ra-
tio
over-
lapped
0.
75 and
1.25
Publi-
cation
bias
could
not be
assessed
be-
cause of
the few
trials
N/A N/A N/A N/A
Table 7. GRADE interventions according to outcomes
Outcome High-certainty evidence Moderate-certainty evidence Low-certainty evidence Very low-cer-
tainty
evidence/no
studies
What works
(Important/
less important
benefit/harm)
What doesn’t
work (no im-
portant bene-
fit/harm)
What proba-
bly works
(Important/
less important
benefit/harm)
What proba-
bly doesn’t
work (no im-
portant bene-
fit/harm)
What may
work (Impor-
tant/less im-
portant bene-
fit/harm)
No current ev-
idence of clear
difference (no
important
benefit/harm)
Uncertainty
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Table 7. GRADE interventions according to outcomes (Continued)
SSI Adhesive drape
(harm)
N/A Antibiotic pro-
phylaxis (her-
nia repair)
Iodine-im-
pregnated ad-
hesive drapes
In-
tra- and post-
operative strict
glycaemic con-
trol with intra-
venous glucose
insulin-potas-
sium infusion
Aqueous solu-
tions
2% iodine in
90% alcohol
Prophylac-
tic intravenous
antibiotics ad-
ministered be-
fore caesarean
incision
N/A Antibiotic pro-
phylaxis (cae-
sarean section)
Duration
of therapy (an-
timicrobial
prophylaxis for
colorectal
surgery)
In-
creased global
blood flow
Double glov-
ing
Iodophor-in-
alcohol paint
Preoper-
ative antibiotic
(breast cancer
surgery)
N/A N/A Antibiotic pro-
phy-
laxis (co-amox-
iclav or cefo-
taxime)
Dis-
posable surgi-
cal face masks
Chlorhexidine
gluconate
N/A N/A N/A N/A N/A PI paint Scalpel versus
electrosurgery
N/A N/A N/A N/A Systemic
antibiotic (IV)
Aqueous PI
scrub
No-scalpel
N/A N/A N/A N/A Antibiotic pro-
phy-
laxis (colorec-
tal surgery)
Cholorhexi-
dine
and cetrimide
scrub
Warming of IV
and irrigation
fluids
N/A N/A N/A N/A Additional aer-
obic cov-
erage (colorec-
tal surgery)
Vaginal prepa-
ration
Intensive
glycaemic con-
trol
N/A N/A N/A N/A Additional
anaerobic cov-
erage (colorec-
tal surgery)
Skin prepara-
tion (drape;
alcohol scrub
with iodophor
drape;
parachlorometaxylenol
with iodine)
Antibiotic pro-
phylaxis
(pefloxacin; er-
tapenem;
cefamandole;
c fazolin and
gentamycin;
cefazolin; van-
comycin and
cefazolin; dap-
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Table 7. GRADE interventions according to outcomes (Continued)
tomycin and
cefazolin; van-
comycin and
cefazolin; dap-
tomycin
and cefazolin;
cephalosporin
drug combina-
tion)
N/A N/A N/A N/A N/A Tech-
niques andma-
terials for skin
closure
IV versus irri-
gation
N/A N/A N/A N/A N/A Microbial
sealant
Antibiotic pro-
phylaxis (elec-
tive laparo-
scopic chole-
cystectomy)
N/A N/A N/A N/A N/A Intra-
and postopera-
tive strict gly-
caemic control
Oral versus in-
travenous (an-
timicrobial
prophylaxis for
colorectal
surgery)
N/A N/A N/A N/A N/A High perioper-
ative inspira-
tory oxygen
Meth-
ods of decreas-
ing infection to
improve
outcomes after
liver resections
N/A N/A N/A N/A N/A Antibiotic pro-
phylaxis (van-
comycin; sin-
gle
cephalosporin)
Perioperative
antibiotics to
prevent infec-
tion after first-
trimester abor-
tion
N/A N/A N/A N/A N/A Com-
bined oral and
IV versus alone
(antimicrobial
prophylaxis for
colorectal
surgery)
Con-
tinuous com-
pared with in-
terrupted skin
sutures
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Table 7. GRADE interventions according to outcomes (Continued)
N/A N/A N/A N/A N/A Intraoper-
ative strict gly-
caemic control
Subcutaneous
closure
N/A N/A N/A N/A N/A N/A Open ver-
sus closed (pri-
mary ver-
sus secondary
intention)
N/A N/A N/A N/A N/A N/A Staples versus
sutures
N/A N/A N/A N/A N/A N/A Tissue ad-
hesives for clo-
sure
Mortality N/A N/A N/A N/A N/A In-
creased global
blood flow
Intensive gly-
caemic control
N/A N/A N/A N/A N/A In-
tra- and post-
operative strict
or Intraopera-
tive strict
glycaemic con-
trol
Long-duration
antibiotics ver-
sus short-dura-
tion antibiotics
N/A N/A N/A N/A N/A High perioper-
ative inspira-
tory oxygen
Topical PI gel
N/A N/A N/A N/A N/A Antibiotic pro-
phy-
laxis (co-amox-
iclav or cefo-
taxime)
Antibiotic pro-
phylaxis (van-
comycin and
cefuroxime)
IV: intravenous; NA: not applicable; PI: povidone iodine; SSI: surgical site infection
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A P P E N D I C E S
Appendix 1. Summary of common topical antiseptics used in preoperative skin decontamination
Antiseptic agents
Alcohol
Alcohol denatures the cell wall proteins of bacteria. Alcohol rubs are usually available in preparations of 60% to 90% strength and are
effective against a wide range of gram-positive and gram-negative bacteria, Mycobacterium tuberculosis, and many fungi and viruses.
The three main alcohols used are ethanol, isopropanol and n-propanol, and some rubs may contain a mixture of these. Alcohol-based
solutions usually (but not always) contain additional active ingredients to combine the rapid bacteriocidal effect of alcohol with more
persistent chemical activity.
Iodine and iodophors
Iodine and iodophors are iodine solutions that are effective against a wide range of gram-positive and gram-negative bacteria, the
tubercle bacillus (TB), fungi and viruses. These penetrate cell walls, then oxidise and substitute the microbial contents with free iodine
(Hardin 1997; Mangram 1999; Warner 1988). Iodophors contain a surfactant or stabilising agent that liberates the free iodine (Wade
1980). Iodophor has largely replaced iodine as the active ingredient in antiseptics. Iodophor comprises free iodine molecules bound
to a polymer such as polyvinyl pyrrolidine (i.e. povidone), so is often termed povidone iodine (PI) (Larson 1995). Typically, 10%
PI formulations contain 1% available iodine (Larson 1995; Reichman 2009). PI is soluble in both water and alcohol, and available
preparations include aqueous iodophor scrub and paint, aqueous iodophor one-step preparation with polymer (3M), and alcoholic
iodophor with water insoluble polymer (DuraPrep).
Chlorhexidine
Chlorhexidine is a biguanide. It is effective against a wide range of gram-positive and gram-negative bacteria, lipophilic viruses and
yeasts. Although its immediate antimicrobial activity is slower than alcohols, it is more persistent because it binds to the outermost
layer of skin.
Triclosan
Triclosan (2,4,4’-trichloro-2’-hydroxydiphenyl ether) has been incorporated in detergents (0.4% to 1%) and alcohols (0.2% to 0.5%)
used for hygienic and surgical hand antisepsis or preoperative skin disinfection. It inhibits Staphylococci, coliforms, enterobacteria and
a wide range of gram-negative intestinal and skin flora.
Appendix 2. Search strategy
#1MeSH descriptor: [Surgical Wound Infection] explode all trees
#2MeSH descriptor: [Surgical Wound Dehiscence] explode all trees
#3(surg* near/5 infect*):ti,ab,kw
#4(surg* near/5 wound*):ti,ab,kw
#5(surg* near/5 site*):ti,ab,kw
#6(surg* near/5 incision*):ti,ab,kw
#7(surg* near/5 dehisc*):ti,ab,kw
#8(wound* near/5 dehisc*):ti,ab,kw
#9(wound* near/5 infect*):ti,ab,kw
#10(wound near/5 disruption*):ti,ab,kw
#11(wound next complication*):ti,ab,kw
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#12{or #1-#11}
#13 {or #1-#11} in Cochrane Reviews (Reviews and protocols)
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(Continued)
Buch-
leit-
ner
2012
Y Y Y Y Y Y Y Y Y PY Y Y PY PY Y Y
Camp-
bell
2015
Y Y Y Y Y Y Y Y Y Y Y N Y PN Y Y
Charoenkwan
2017
Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y
Cook
2014
Y Y Y Y Y N Y PN PN PN PN PN PN PN PY PN
Dumville
2014
Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y
Dumville
2015
Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y
Gro-
cott
2012
Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y
Gyte
2014
Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y
Gu-
rusamy
2011
Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y
Gu-
rusamy
2013
Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y
Gu-
rusamy
2014a
Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y
Gu-
rusamy
2014b
Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y
Haas
2014
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(Continued)
Ha-
diati
2014
Y Y Y Y Y Y Y Y Y Y Y PN PY PY Y Y
Jones
2014
Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y
Kao
2009
Y Y Y Y Y Y Y Y Y PY PY PN PY PY Y Y
Lipp
2013
Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y
Low
2012
Y Y Y Y Y N Y Y Y Y Y Y Y Y Y Y
Mac-
keen
2012
Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y
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2014
Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y
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han
2016
Y Y Y Y Y Y Y Y Y Y Y PY Y Y Y Y
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2014
Y Y Y Y Y PY Y Y Y Y Y Y Y Y Y Y
Sanabria
2010
Y Y Y Y Y PY Y Y Y Y Y Y Y Y Y Y
Sanchez-
Manuel
2012
Y Y Y Y Y N Y Y Y Y Y Y Y Y Y Y
Smaill
2014
Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y
Tan-
ner
2006
Y Y Y Y Y N Y Y Y PY PY N PY PY Y Y
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(Continued)
Vin-
cent
2016
Y Y Y Y Y Y Y Y Y PY PY PN PY PY Y Y
Web-
ster
2015
Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y
Wet-
ter-
slev
2015
Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y
Wood
2016
Y Y Y Y Y Y Y Y Y PY Y N PY PY Y Y
Footnotes
Y = yes; PY = probably yes; N = no; and PN = probably no
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